813 results on '"Taylor SA"'
Search Results
2. Cognitive aids used in simulated resuscitation: A systematic review
- Author
-
Sabine Nabecker, Kevin Nation, Elaine Gilfoyle, Cristian Abelairas-Gomez, Elina Koota, Yiqun Lin, Robert Greif, Natalie Anderson, Farhan Bhanji, Jan Breckwoldt, Adam Cheng, Andrea Cortegiani, Aaron Donoghue, Kathryn Eastwood, Barbara Farquharson, Ming-Ju Hiseih, Ying- Chih Ko, Kasper G. Lauridsen, Yiquin Lin, Andrew Lockey, Tasuku Mastsuyama, Alexander Olaussen, Taylor Sawyer, Sebastian Schnaubelt, Chih-Wei Yang, and Joyce Yeung
- Subjects
Cognitive aids ,Cardiopulmonary resuscitation ,Basic and advanced life support ,Simulation ,Checklist ,Specialties of internal medicine ,RC581-951 - Abstract
Objectives: To compare the effectiveness of cognitive aid use during resuscitation with no use of cognitive aids on cardiopulmonary resuscitation quality and performance. Methods: This systematic review followed the PICOST format. All randomised controlled trials and non-randomised studies evaluating cognitive aid use during (simulated) resuscitation were included in any setting. Unpublished studies were excluded. We did not include studies that reported cognitive aid use during training for resuscitation alone. Medline, Embase and Cochrane databases were searched from inception until July 2019 (updated August 2022, November 2023, and 23 April 2024). We did not search trial registries. Title and abstract screening, full-text screening, data extraction, risk of bias assessment (using RoB2 and ROBINS-I), and certainty of evidence (using GRADE) were performed by two researchers. PRISMA reporting standards were followed, and registration (PROSPERO CRD42020159162, version 19 July 2022) was performed. No funding has been obtained. Results: The literature search identified 5029 citations. After removing 512 duplicates, reviewing the titles and abstracts of the remaining articles yielded 103 articles for full-text review. Hand-searching identified 3 more studies for full-text review. Of these, 29 studies were included in the final analysis. No clinical studies involving patients were identified. The review was limited to indirect evidence from simulation studies only. The results are presented in five different populations: healthcare professionals managing simulated resuscitations in neonates, children, adult advanced life support, and other emergencies; as well as lay providers managing resuscitations. Main outcomes were adherence to protocol or process, adherence to protocol or process assessed by performance score, CPR performance and retention, and feasibility of chatbot guidance. The risk of bias assessment ranged from low to high. Studies in neonatal, paediatric and adult life support delivered by healthcare professionals showed benefits of using cognitive aids, however, some studies evaluating resuscitations by lay providers reported undesirable effects. The performance of a meta-analysis was not possible due to significant methodological heterogeneity. The certainty of evidence was rated as moderate to very low due to serious indirectness, (very) serious risk of bias, serious inconsistency and (very) serious imprecision. Conclusion: Because of the very low certainty evidence from simulation studies, we suggest that cognitive aids should be used by healthcare professionals during resuscitation. In contrast, we do not suggest use of cognitive aids for lay providers, based on low certainty evidence.
- Published
- 2024
- Full Text
- View/download PDF
3. Functional connectivity development along the sensorimotor-association axis enhances the cortical hierarchy
- Author
-
Audrey C. Luo, Valerie J. Sydnor, Adam Pines, Bart Larsen, Aaron F. Alexander-Bloch, Matthew Cieslak, Sydney Covitz, Andrew A. Chen, Nathalia Bianchini Esper, Eric Feczko, Alexandre R. Franco, Raquel E. Gur, Ruben C. Gur, Audrey Houghton, Fengling Hu, Arielle S. Keller, Gregory Kiar, Kahini Mehta, Giovanni A. Salum, Tinashe Tapera, Ting Xu, Chenying Zhao, Taylor Salo, Damien A. Fair, Russell T. Shinohara, Michael P. Milham, and Theodore D. Satterthwaite
- Subjects
Science - Abstract
Abstract Human cortical maturation has been posited to be organized along the sensorimotor-association axis, a hierarchical axis of brain organization that spans from unimodal sensorimotor cortices to transmodal association cortices. Here, we investigate the hypothesis that the development of functional connectivity during childhood through adolescence conforms to the cortical hierarchy defined by the sensorimotor-association axis. We tested this pre-registered hypothesis in four large-scale, independent datasets (total n = 3355; ages 5–23 years): the Philadelphia Neurodevelopmental Cohort (n = 1207), Nathan Kline Institute-Rockland Sample (n = 397), Human Connectome Project: Development (n = 625), and Healthy Brain Network (n = 1126). Across datasets, the development of functional connectivity systematically varied along the sensorimotor-association axis. Connectivity in sensorimotor regions increased, whereas connectivity in association cortices declined, refining and reinforcing the cortical hierarchy. These consistent and generalizable results establish that the sensorimotor-association axis of cortical organization encodes the dominant pattern of functional connectivity development.
- Published
- 2024
- Full Text
- View/download PDF
4. Gamified learning for resuscitation education: A systematic review
- Author
-
Aaron Donoghue, Taylor Sawyer, Alexander Olaussen, Robert Greif, and Lorrel Toft
- Subjects
Life support education ,Gamified learning ,Cardiopulmonary resuscitation ,Specialties of internal medicine ,RC581-951 - Abstract
Aim: To systematically review published literature to evaluate the impact of gamified learning on educational and clinical outcomes during life support education. Methods: This systematic review was conducted as part of the continuous evidence evaluation process of the International Liaison Committee on Resuscitation (ILCOR). A search of PubMed, Embase, and Cochrane was conducted from inception until February 12, 2024. Studies examining incorporation of gamified learning were eligible for inclusion. Reviewers independently extracted data on study design and outcomes; appropriate risk of bias assessment tools were used across all outcomes. Results: 2261 articles were identified and screened, yielding sixteen articles (seven randomized trials, nine observational studies) which comprised the final review. No meta-analyses were conducted due to significant heterogeneity of intervention, population, and outcome. Only one study was found to have a low risk of bias; the remaining studies were found to have moderate to high risk. Fourteen studies were in healthcare providers and two were in laypersons. Most studies (11 of 16) examined the impact of a digital platform (computer or smartphone). Most (15 of 16) studies found a positive effect on at least one educational domain; one study found no effect. No included study found a negative effect on any educational domain. Conclusion: This systematic review found a very heterogeneous group of studies with low certainty evidence, all but one of which demonstrated a positive effect on one or more educational domains. Future studies should examine the underlying causes of improved learning with gamification and assess the resource requirements with implementation and dissemination of gamified learning.
- Published
- 2024
- Full Text
- View/download PDF
5. Rapid cycle deliberate practice approach on resuscitation training: A systematic review
- Author
-
Cristian Abelairas-Gómez, Andrea Cortegiani, Taylor Sawyer, Robert Greif, and Aaron Donoghue
- Subjects
Medical education ,Simulation ,Debriefing ,Basic life support ,Advance cardiac life support ,Learning ,Specialties of internal medicine ,RC581-951 - Abstract
Aim: To evaluate the effectiveness of Rapid Cycle Deliberate Practice (RCDP) compared to traditional instruction or other forms of learning on resuscitation training outcomes and on clinical and/or patient-related outcomes. Methods: As part of the continuous evidence evaluation process of the International Liaison Committee on Resuscitation it was conducted this review and searched Medline, Embase and Cochrane from inception to Feb 12th, 2024. Risk of bias assessment was performed with the Risk of Bias in Non-randomized Studies of Interventions assessment tool and the Revised Cochrane risk-of-bias tool for randomized trials. The GRADE approach was used to evaluate the overall certainty of evidence for each outcome. Results: 4420 abstracts were retrieved by the initial search and 10 additional studies were identified through other resources. Sixty-five studies were selected for eligibility and nine simulated studies met the inclusion criteria. A meta-analysis was performed on three outcomes: time to chest compressions, time to defibrillation and time to first epinephrine given, which showed that RCDP had significantly shorter time to defibrillation and time to administration of epinephrine than controls. The overall certainty of evidence was very low across all outcomes due to risk of bias, inconsistency, indirectness, and imprecision. Conclusion: It may be reasonable to include RCDP as an instructional design feature of basic and advanced life support training. However, substantial variations of delivering RCDP exist and there is no uniform use of RCDP. Further research is necessary on medium/long-term effects of RCDP training, and on the effects on different target groups of training.
- Published
- 2024
- Full Text
- View/download PDF
6. ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in IBD
- Author
-
Kucharzik, T, Tielbeek, J, Carter, D, Taylor, SA, Tolan, D, Wilkens, R, Bryant, RV, Hoeffel, C, De Kock, Isabelle, Maaser, C, Maconi, G, Novak, K, Rafaelsen, SR, Scharitzer, M, Spinelli, A, Rimola, J, Centre de Recherche en Sciences et Technologies de l'Information et de la Communication - EA 3804 (CRESTIC), and Université de Reims Champagne-Ardenne (URCA)
- Subjects
reporting ,INTESTINAL ULTRASOUND ,GUIDED PERCUTANEOUS DRAINAGE ,RECTOVAGINAL FISTULAS ,intestinal ultrasound [IUS] ,MAGNETIC-RESONANCE ENTEROGRAPHY ,PERIANAL CROHNS-DISEASE ,POSTOPERATIVE RECURRENCE ,cross-sectional imaging ,ULCERATIVE-COLITIS ,magnetic resonance imaging [MRI] ,Medicine and Health Sciences ,[INFO.INFO-IM]Computer Science [cs]/Medical Imaging ,endoanal ultrasonography [EAUS] ,transperineal ultrasonography [PUS ,MR ENTEROGRAPHY ,ENDOSCOPIC ULTRASOUND ,CONTRAST-ENHANCED ULTRASOUND ,Inflammatory bowel disease [IBD] - Abstract
International audience; Abstract Background and Aims Diagnosis and follow up of patients with inflammatory bowel disease [IBD] requires cross-sectional imaging modalities, such as intestinal ultrasound [IUS], magnetic resonance imaging [MRI], and computed tomography [CT]. The quality and homogeneity of medical reporting are crucial to ensure effective communication between specialists and to improve patient care. The current topical review addresses optimized reporting requirements for cross-sectional imaging in IBD. Methods An expert consensus panel consisting of gastroenterologists, radiologists, and surgeons convened by the ECCO in collaboration with ESGAR performed a systematic literature review covering the reporting aspects of MRI, CT, IUS, endoanal ultrasonography, and transperineal ultrasonography in IBD. Practice position statements were developed utilizing a Delphi methodology incorporating two consecutive rounds. Current practice positions were set when ≥80% of the participants agreed on a recommendation. Results Twenty-five practice positions were developed, establishing standard terminology for optimal reporting in cross-sectional imaging. Assessment of inflammation, complications, and imaging of perianal CD are outlined. The minimum requirements of a standardized report, including a list of essential reporting items, have been defined. Conclusions This topical review offers practice recommendations to optimize and homogenize reporting in cross-sectional imaging in IBD.
- Published
- 2021
7. Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn's disease
- Author
-
Goodsall, TM, Jairath, V, Feagan, BG, Parker, CE, Nguyen, TM, Guizzetti, L, Asthana, AK, Begun, J, Christensen, B, Friedman, AB, Kucharzik, T, Lee, A, Lewindon, PJ, Maaser, C, Novak, KL, Rimola, J, Taylor, KM, Taylor, SA, White, LS, Wilkens, R, Wilson, SR, Wright, EK, Bryant, RV, Ma, C, Goodsall, TM, Jairath, V, Feagan, BG, Parker, CE, Nguyen, TM, Guizzetti, L, Asthana, AK, Begun, J, Christensen, B, Friedman, AB, Kucharzik, T, Lee, A, Lewindon, PJ, Maaser, C, Novak, KL, Rimola, J, Taylor, KM, Taylor, SA, White, LS, Wilkens, R, Wilson, SR, Wright, EK, Bryant, RV, and Ma, C
- Abstract
BACKGROUND: Intestinal ultrasound (IUS) is a valuable tool for assessment of Crohn's disease (CD). However, there is no widely accepted luminal disease activity index. AIMS: To identify appropriate IUS protocols, indices, items, and scoring methods for measurement of luminal CD activity and integration of IUS in CD clinical trials. METHODS: An expert international panel of adult and paediatric gastroenterologists (n = 15) and radiologists (n = 3) rated the appropriateness of 120 statements derived from literature review and expert opinion (scale of 1-9) using modified RAND/UCLA methodology. Median panel scores of 1 to ≤3.5, >3.5 to <6.5 and ≥6.5 to 9 were considered inappropriate, uncertain and appropriate ratings respectively. The statement list and survey results were discussed prior to voting. RESULTS: A total of 91 statements were rated appropriate with agreement after two rounds of voting. Items considered appropriate measures of disease activity were bowel wall thickness (BWT), vascularity, stratification and mesenteric inflammatory fat. There was uncertainty if any of the existing IUS disease activity indices were appropriate for use in CD clinical trials. Appropriate trial applications for IUS included patient recruitment qualification when diseased segments cannot be adequately assessed by ileocolonoscopy and screening for exclusionary complications. At outcome assessment, remission endpoints including BWT and vascularity, with or without mesenteric inflammatory fat, were considered appropriate. Components of an ideal IUS disease activity index were identified based upon panel discussions. CONCLUSIONS: The panel identified appropriate component items and applications of IUS for CD clinical trials. Empiric evidence, and development and validation of an IUS disease activity index are needed.
- Published
- 2021
8. Dense sampling of bird diversity increases power of comparative genomics (vol 587, pg 252, 2020)
- Author
-
Feng, S, Stiller, J, Deng, Y, Armstrong, J, Fang, Q, Reeve, AH, Xie, D, Chen, G, Guo, C, Faircloth, BC, Petersen, B, Wang, Z, Zhou, Q, Diekhans, M, Chen, W, Andreu-Sanchez, S, Margaryan, A, Howard, JT, Parent, C, Pacheco, G, Sinding, M-HS, Puetz, L, Cavill, E, Ribeiro, AM, Eckhart, L, Fjeldsa, J, Hosner, PA, Brumfield, RT, Christidis, L, Bertelsen, MF, Sicheritz-Ponten, T, Tietze, DT, Robertson, BC, Song, G, Borgia, G, Claramunt, S, Lovette, IJ, Cowen, SJ, Njoroge, P, Dumbacher, JP, Ryder, OA, Fuchs, J, Bunce, M, Burt, DW, Cracraft, J, Meng, G, Hackett, SJ, Ryan, PG, Jonsson, KA, Jamieson, IG, da Fonseca, RR, Braun, EL, Houde, P, Mirarab, S, Suh, A, Hansson, B, Ponnikas, S, Sigeman, H, Stervander, M, Frandsen, PB, van der Zwan, H, van der Sluis, R, Visser, C, Balakrishnan, CN, Clark, AG, Fitzpatrick, JW, Bowman, R, Chen, N, Cloutier, A, Sackton, TB, Edwards, SV, Foote, DJ, Shakya, SB, Sheldon, FH, Vignal, A, Soares, AER, Shapiro, B, Gonzalez-Solis, J, Ferrer-Obiol, J, Rozas, J, Riutort, M, Tigano, A, Friesen, V, Dalen, L, Urrutia, AO, Szekely, T, Liu, Y, Campana, MG, Corvelo, A, Fleischer, RC, Rutherford, KM, Gemmell, NJ, Dussex, N, Mouritsen, H, Thiele, N, Delmore, K, Liedvogel, M, Franke, A, Hoeppner, MP, Krone, O, Fudickar, AM, Mila, B, Ketterson, ED, Fidler, AE, Friis, G, Parody-Merino, AM, Battley, PF, Cox, MP, Lima, NCB, Prosdocimi, F, Parchman, TL, Schlinger, BA, Loiselle, BA, Blake, JG, Lim, HC, Day, LB, Fuxjager, MJ, Baldwin, MW, Braun, MJ, Wirthlin, M, Dikow, RB, Ryder, TB, Camenisch, G, Keller, LF, DaCosta, JM, Hauber, ME, Louder, MIM, Witt, CC, McGuire, JA, Mudge, J, Megna, LC, Carling, MD, Wang, B, Taylor, SA, Del-Rio, G, Aleixo, A, Vasconcelos, ATR, Mello, CV, Weir, JT, Haussler, D, Li, Q, Yang, H, Wang, J, Lei, F, Rahbek, C, Gilbert, MTP, Graves, GR, Jarvis, ED, Paten, B, Zhang, G, Feng, S, Stiller, J, Deng, Y, Armstrong, J, Fang, Q, Reeve, AH, Xie, D, Chen, G, Guo, C, Faircloth, BC, Petersen, B, Wang, Z, Zhou, Q, Diekhans, M, Chen, W, Andreu-Sanchez, S, Margaryan, A, Howard, JT, Parent, C, Pacheco, G, Sinding, M-HS, Puetz, L, Cavill, E, Ribeiro, AM, Eckhart, L, Fjeldsa, J, Hosner, PA, Brumfield, RT, Christidis, L, Bertelsen, MF, Sicheritz-Ponten, T, Tietze, DT, Robertson, BC, Song, G, Borgia, G, Claramunt, S, Lovette, IJ, Cowen, SJ, Njoroge, P, Dumbacher, JP, Ryder, OA, Fuchs, J, Bunce, M, Burt, DW, Cracraft, J, Meng, G, Hackett, SJ, Ryan, PG, Jonsson, KA, Jamieson, IG, da Fonseca, RR, Braun, EL, Houde, P, Mirarab, S, Suh, A, Hansson, B, Ponnikas, S, Sigeman, H, Stervander, M, Frandsen, PB, van der Zwan, H, van der Sluis, R, Visser, C, Balakrishnan, CN, Clark, AG, Fitzpatrick, JW, Bowman, R, Chen, N, Cloutier, A, Sackton, TB, Edwards, SV, Foote, DJ, Shakya, SB, Sheldon, FH, Vignal, A, Soares, AER, Shapiro, B, Gonzalez-Solis, J, Ferrer-Obiol, J, Rozas, J, Riutort, M, Tigano, A, Friesen, V, Dalen, L, Urrutia, AO, Szekely, T, Liu, Y, Campana, MG, Corvelo, A, Fleischer, RC, Rutherford, KM, Gemmell, NJ, Dussex, N, Mouritsen, H, Thiele, N, Delmore, K, Liedvogel, M, Franke, A, Hoeppner, MP, Krone, O, Fudickar, AM, Mila, B, Ketterson, ED, Fidler, AE, Friis, G, Parody-Merino, AM, Battley, PF, Cox, MP, Lima, NCB, Prosdocimi, F, Parchman, TL, Schlinger, BA, Loiselle, BA, Blake, JG, Lim, HC, Day, LB, Fuxjager, MJ, Baldwin, MW, Braun, MJ, Wirthlin, M, Dikow, RB, Ryder, TB, Camenisch, G, Keller, LF, DaCosta, JM, Hauber, ME, Louder, MIM, Witt, CC, McGuire, JA, Mudge, J, Megna, LC, Carling, MD, Wang, B, Taylor, SA, Del-Rio, G, Aleixo, A, Vasconcelos, ATR, Mello, CV, Weir, JT, Haussler, D, Li, Q, Yang, H, Wang, J, Lei, F, Rahbek, C, Gilbert, MTP, Graves, GR, Jarvis, ED, Paten, B, and Zhang, G
- Abstract
A Correction to this paper has been published: https://doi.org/10.1038/s41586-021-03473-8.
- Published
- 2021
9. The Advantage of Low and Medium Attractiveness for Facial Composite Production from Modern Forensic Systems
- Author
-
Richardson, BH, Brown, C, Heard, P, Pitchford, M, Portch, E, Lander, K, Marsh, JE, Bell, R, Fodarella, C, Taylor, SA, Worthington, M, Ellison, L, Charters, P, Green, D, Minahil, S, and Frowd, CD
- Abstract
Recognition following long delays is superior for highly attractive and highly unattractive faces (cf. medium-attractive faces). In the current work, we investigated participants’ ability to recreate from memory faces of low, medium, and high physical attractiveness. In Experiment 1, participants constructed composites of familiar (celebrity) faces using the holistic EvoFIT system. When controlling for other variables that may influence face recognition (memorability, familiarity, likeability, and age), correct naming and ratings of likeness were superior for composites of low attractiveness targets. Experiment 2 replicated this design using the feature-based PRO-fit system, revealing superiority (by composite naming and ratings of likeness) for medium attractiveness. In Experiment 3, participants constructed composites of unfamiliar faces after a forensically relevant delay of 1 day. Using ratings of likeness as a measure of composite effectiveness, these same effects were observed for EvoFIT and PRO-fit. The work demonstrates the importance of attractiveness for method of composite face construction.
- Published
- 2020
10. European society of neurogastroenterology and motility guidelines on functional constipation in adults
- Author
-
Serra, J, Pohl, D, Azpiroz, F, Chiarioni, G, Ducrotte, P, Gourcerol, G, Hungin, APS, Layer, P, Mendive, JM, Pfeifer, J, Rogler, G, Scott, SM, Simren, M, Whorwell, P, Aguilar, A, Caballero, N, Schindler, V, Popa, SL, Malagelada, C, Andresen, V, Waha, JE, Grossi, U, Taylor, SA, Hassan, SS, douville, sabine, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Badalona, Spain., Motility and Functional Gut Disorders Unit, University Hospital Germans Trias i Pujol, Badalona, Spain., Universitat Autònoma de Barcelona (UAB), Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland., University hospital of Zurich [Zurich], Digest Syst Res Unit, Vall Hebron Inst Recerca, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Division of Gastroenterology B, AOUI Verona, Verona, Italy., UNC Center for Functional GI and Motility Disorders, University of North Carolina, Chapel Hill, NC, USA., Service d'Hépato-Gastroentérologie [CHU Rouen], Hôpital Charles Nicolle [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Nutrition, inflammation et dysfonctionnement de l'axe intestin-cerveau (ADEN), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institute for Research and Innovation in Biomedicine (IRIB), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), UNIROUEN - UFR Santé (UNIROUEN UFR Santé), Normandie Université (NU)-Normandie Université (NU), Service de physiologie digestive, urinaire, respiratoire et de l'exercice [CHU Rouen], General Practice, Faculty of Medical Sciences, Newcastle University, Newcastle, UK., Israelitic Hospital, Sant Adrià de Besòs (Barcelona) Catalan Institut of Health (ICS), La Mina Primary Health Care Centre, Badalona, Spain., Department of Surgery, Division of General Surgery, Medical University of Graz, Graz, Austria., Division of Gastroenterology and Hepatology [Zurich], Universität Zürich [Zürich] = University of Zurich (UZH)-University hospital of Zurich [Zurich], Division of Gastroenterology, University Hospital Zurich, Zurich, Switzerland., Neurogastroenterology Group, Centre for Neuroscience, Surgery and Trauma, Blizard Institute, Barts, UK., The London School of Medicine & Dentistry, Queen Mary University London, London, UK, University of Gothenburg (GU), Division of Diabetes, Endocrinology & Gastroenterology, Neurogastroenterology Unit, Wythenshawe Hospital, University of Manchester, Manchester, UK., Functional Constipation Guidelines Working Group, Department of Medicine, Autonomous University of Barcelona, Badalona, Spain., Hôpital Charles Nicolle [Rouen]-CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Internal Medicine & Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., University of Zurich, and Serra, Jordi
- Subjects
Adult ,Male ,chronic constipation ,Delphi process ,guidelines ,management of constipation ,medicine.medical_specialty ,Constipation ,Physiology ,Population ,610 Medicine & health ,Colonic Diseases, Functional ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,Humans ,2715 Gastroenterology ,education ,Intensive care medicine ,Linaclotide ,ComputingMilieux_MISCELLANEOUS ,education.field_of_study ,Chronic constipation ,Prucalopride ,business.industry ,Endocrine and Autonomic Systems ,Gastroenterology ,[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology ,Evidence-based medicine ,1314 Physiology ,medicine.disease ,Lubiprostone ,[SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology ,3. Good health ,2807 Endocrine and Autonomic Systems ,10219 Clinic for Gastroenterology and Hepatology ,chemistry ,030220 oncology & carcinogenesis ,Functional constipation ,Female ,030211 gastroenterology & hepatology ,medicine.symptom ,business ,medicine.drug - Abstract
INTRODUCTION: Chronic constipation is a common disorder with a reported prevalence ranging from 3% to 27% in the general population. Several management strategies, including diagnostic tests, empiric treatments, and specific treatments, have been developed. Our aim was to develop European guidelines for the clinical management of constipation.DESIGN: After a thorough review of the literature by experts in relevant fields, including gastroenterologists, surgeons, general practitioners, radiologists, and experts in gastrointestinal motility testing from various European countries, a Delphi consensus process was used to produce statements and practical algorithms for the management of chronic constipation.KEY RESULTS: Seventy-three final statements were agreed upon after the Delphi process. The level of evidence for most statements was low or very low. A high level of evidence was agreed only for anorectal manometry as a comprehensive evaluation of anorectal function and for treatment with osmotic laxatives, especially polyethylene glycol, the prokinetic drug prucalopride, secretagogues, such as linaclotide and lubiprostone and PAMORAs for the treatment of opioid-induced constipation. However, the level of agreement between the authors was good for most statements (80% or more of the authors). The greatest disagreement was related to the surgical management of constipation.CONCLUSIONS AND INFERENCES: European guidelines on chronic constipation, with recommendations and algorithms, were developed by experts. Despite the high level of agreement between the different experts, the level of scientific evidence for most recommendations was low, highlighting the need for future research to increase the evidence and improve treatment outcomes in these patients.
- Published
- 2020
11. Dense sampling of bird diversity increases power of comparative genomics
- Author
-
Feng, S, Stiller, J, Deng, Y, Armstrong, J, Fang, Q, Reeve, AH, Xie, D, Chen, G, Guo, C, Faircloth, BC, Petersen, B, Wang, Z, Zhou, Q, Diekhans, M, Chen, W, Andreu-Sanchez, S, Margaryan, A, Howard, JT, Parent, C, Pacheco, G, Sinding, M-HS, Puetz, L, Cavill, E, Ribeiro, AM, Eckhart, L, Fjeldsa, J, Hosner, PA, Brumfield, RT, Christidis, L, Bertelsen, MF, Sicheritz-Ponten, T, Tietze, DT, Robertson, BC, Song, G, Borgia, G, Claramunt, S, Lovette, IJ, Cowen, SJ, Njoroge, P, Dumbacher, JP, Ryder, OA, Fuchs, J, Bunce, M, Burt, DW, Cracraft, J, Meng, G, Hackett, SJ, Ryan, PG, Jonsson, KA, Jamieson, IG, da Fonseca, RR, Braun, EL, Houde, P, Mirarab, S, Suh, A, Hansson, B, Ponnikas, S, Sigeman, H, Stervander, M, Frandsen, PB, van der Zwan, H, van der Sluis, R, Visser, C, Balakrishnan, CN, Clark, AG, Fitzpatrick, JW, Bowman, R, Chen, N, Cloutier, A, Sackton, TB, Edwards, SV, Foote, DJ, Shakya, SB, Sheldon, FH, Vignal, A, Soares, AER, Shapiro, B, Gonzalez-Solis, J, Ferrer-Obiol, J, Rozas, J, Riutort, M, Tigano, A, Friesen, V, Dalen, L, Urrutia, AO, Szekely, T, Liu, Y, Campana, MG, Corvelo, A, Fleischer, RC, Rutherford, KM, Gemmell, NJ, Dussex, N, Mouritsen, H, Thiele, N, Delmore, K, Liedvogel, M, Franke, A, Hoeppner, MP, Krone, O, Fudickar, AM, Mila, B, Ketterson, ED, Fidler, AE, Friis, G, Parody-Merino, AM, Battley, PF, Cox, MP, Lima, NCB, Prosdocimi, F, Parchman, TL, Schlinger, BA, Loiselle, BA, Blake, JG, Lim, HC, Day, LB, Fuxjager, MJ, Baldwin, MW, Braun, MJ, Wirthlin, M, Dikow, RB, Ryder, TB, Camenisch, G, Keller, LF, DaCosta, JM, Hauber, ME, Louder, MIM, Witt, CC, McGuire, JA, Mudge, J, Megna, LC, Carling, MD, Wang, B, Taylor, SA, Del-Rio, G, Aleixo, A, Vasconcelos, ATR, Mello, CV, Weir, JT, Haussler, D, Li, Q, Yang, H, Wang, J, Lei, F, Rahbek, C, Gilbert, MTP, Graves, GR, Jarvis, ED, Paten, B, Zhang, G, Feng, S, Stiller, J, Deng, Y, Armstrong, J, Fang, Q, Reeve, AH, Xie, D, Chen, G, Guo, C, Faircloth, BC, Petersen, B, Wang, Z, Zhou, Q, Diekhans, M, Chen, W, Andreu-Sanchez, S, Margaryan, A, Howard, JT, Parent, C, Pacheco, G, Sinding, M-HS, Puetz, L, Cavill, E, Ribeiro, AM, Eckhart, L, Fjeldsa, J, Hosner, PA, Brumfield, RT, Christidis, L, Bertelsen, MF, Sicheritz-Ponten, T, Tietze, DT, Robertson, BC, Song, G, Borgia, G, Claramunt, S, Lovette, IJ, Cowen, SJ, Njoroge, P, Dumbacher, JP, Ryder, OA, Fuchs, J, Bunce, M, Burt, DW, Cracraft, J, Meng, G, Hackett, SJ, Ryan, PG, Jonsson, KA, Jamieson, IG, da Fonseca, RR, Braun, EL, Houde, P, Mirarab, S, Suh, A, Hansson, B, Ponnikas, S, Sigeman, H, Stervander, M, Frandsen, PB, van der Zwan, H, van der Sluis, R, Visser, C, Balakrishnan, CN, Clark, AG, Fitzpatrick, JW, Bowman, R, Chen, N, Cloutier, A, Sackton, TB, Edwards, SV, Foote, DJ, Shakya, SB, Sheldon, FH, Vignal, A, Soares, AER, Shapiro, B, Gonzalez-Solis, J, Ferrer-Obiol, J, Rozas, J, Riutort, M, Tigano, A, Friesen, V, Dalen, L, Urrutia, AO, Szekely, T, Liu, Y, Campana, MG, Corvelo, A, Fleischer, RC, Rutherford, KM, Gemmell, NJ, Dussex, N, Mouritsen, H, Thiele, N, Delmore, K, Liedvogel, M, Franke, A, Hoeppner, MP, Krone, O, Fudickar, AM, Mila, B, Ketterson, ED, Fidler, AE, Friis, G, Parody-Merino, AM, Battley, PF, Cox, MP, Lima, NCB, Prosdocimi, F, Parchman, TL, Schlinger, BA, Loiselle, BA, Blake, JG, Lim, HC, Day, LB, Fuxjager, MJ, Baldwin, MW, Braun, MJ, Wirthlin, M, Dikow, RB, Ryder, TB, Camenisch, G, Keller, LF, DaCosta, JM, Hauber, ME, Louder, MIM, Witt, CC, McGuire, JA, Mudge, J, Megna, LC, Carling, MD, Wang, B, Taylor, SA, Del-Rio, G, Aleixo, A, Vasconcelos, ATR, Mello, CV, Weir, JT, Haussler, D, Li, Q, Yang, H, Wang, J, Lei, F, Rahbek, C, Gilbert, MTP, Graves, GR, Jarvis, ED, Paten, B, and Zhang, G
- Abstract
Whole-genome sequencing projects are increasingly populating the tree of life and characterizing biodiversity1-4. Sparse taxon sampling has previously been proposed to confound phylogenetic inference5, and captures only a fraction of the genomic diversity. Here we report a substantial step towards the dense representation of avian phylogenetic and molecular diversity, by analysing 363 genomes from 92.4% of bird families-including 267 newly sequenced genomes produced for phase II of the Bird 10,000 Genomes (B10K) Project. We use this comparative genome dataset in combination with a pipeline that leverages a reference-free whole-genome alignment to identify orthologous regions in greater numbers than has previously been possible and to recognize genomic novelties in particular bird lineages. The densely sampled alignment provides a single-base-pair map of selection, has more than doubled the fraction of bases that are confidently predicted to be under conservation and reveals extensive patterns of weak selection in predominantly non-coding DNA. Our results demonstrate that increasing the diversity of genomes used in comparative studies can reveal more shared and lineage-specific variation, and improve the investigation of genomic characteristics. We anticipate that this genomic resource will offer new perspectives on evolutionary processes in cross-species comparative analyses and assist in efforts to conserve species.
- Published
- 2020
12. Developing a core outcome set for fistulising perianal Crohn’s disease
- Author
-
Sahnan, K, Tozer, PJ, Adegbola, SO, Lee, MJ, Heywood, N, McNair, AGK, Hind, D, Yassin, N, Lobo, AJ, Brown, SR, Sebastian, S, Phillips, RKS, Lung, PFC, Faiz, OD, Crook, K, Blackwell, S, Verjee, A, Hart, AL, Fearnhead, NS, John, A, Austin, A, Simon, A, Aidan, A, James, A, Katherine, A, Sathish, B, Ian, B, Gauraang, B, Stuart, B, Dominic, B, Matthew, B, David, B, Jeffrey, B, Christopher, C, Rachel, C, Peter, C, Thomas, C, Tamzin, C, Robert, D, Walter, D, Irene, D, Jayne, E, Jonathan, E, Martyn, E, Simon, F, Beverley, F, Catherine, F, James, G, Catherine, G, Ben, G, Arun, G, Sanjay, G, Richard, G, Alex, H, Diane, H, Nigel, H, Steve, H, Laura, H, Marcus, H, Rachel, H, Barney, H, Bu, H, Emma, H, Paul, H, Tim, H, Stephen, H, Rajapandian, I, Matthew, J, Cheryl, K, Kennedy, NA, Fevronia, K, Charles, K, Bee, L, Wendy, L, Jimmy, L, Richard, L, Peter, M, Janis, M, Steven, M, John, M, Michele, M, Charles, M-A, Alistair, M, Jasbir, N, Arvind, P, Gareth, P, Rajan, P, Uday, P, Leon, P, Kathryn, P, Thomas, P, Katie, P, Richard, P, Niall, P, Mark, P, Abdul, R, Kerry, R, Dan, R, Russell, RK, Mathew, R, Suzanne, R, Judith, S, John, S, Christian, S, Irshad, S, Ian, S, Baljit, S, Ederis, S, Christopher, S, Neil, S, Adam, S, Ben, S, Taylor, SA, Julian, T, Tham, TC, Pradeep, T, John, T, Jared, T, Simon, T, Mark, T, Tracey, T, Christos, T, Carolynne, V, Oliver, W, Janindra, W, Emma, W, Debbie, W, Graham, W, Mark, W, Graeme, W, Eleanor, W, Hannah, Y, Lisa, Y, and Royal College of Surgeons of England
- Subjects
PROTOCOL ,0301 basic medicine ,Research design ,Delphi Technique ,Consensus Development Conferences as Topic ,Delphi method ,ENiGMA collaborators ,0302 clinical medicine ,Crohn Disease ,Quality of life ,Risk Factors ,Outcome Assessment, Health Care ,Medicine ,ANTI-TNF ,Response rate (survey) ,FISTULAS ,Gastroenterology ,TRIALS ,crohn’s disease ,Systematic review ,Centre for Surgical Research ,Research Design ,Disease Progression ,030211 gastroenterology & hepatology ,Life Sciences & Biomedicine ,STEM-CELLS ,medicine.medical_specialty ,Likert scale ,Interviews as Topic ,Outcome Assessment (Health Care) ,03 medical and health sciences ,Crohn Disease/pathology ,MANAGEMENT ,Rectal Fistula ,Humans ,Patient Reported Outcome Measures ,clinical trials ,Science & Technology ,Gastroenterology & Hepatology ,business.industry ,Inflammatory Bowel Disease ,Perianal Abscess ,ibd ,1103 Clinical Sciences ,CARE ,Clinical trial ,030104 developmental biology ,Family medicine ,Quality of Life ,1114 Paediatrics and Reproductive Medicine ,Rectal Fistula/pathology ,anal sepsis ,business ,COSTS ,Fecal Incontinence ,Fecal Incontinence/etiology ,Systematic Reviews as Topic - Abstract
ObjectiveLack of standardised outcomes hampers effective analysis and comparison of data when comparing treatments in fistulising perianal Crohn’s disease (pCD). Development of a standardised set of outcomes would resolve these issues. This study provides the definitive core outcome set (COS) for fistulising pCD.DesignCandidate outcomes were generated through a systematic review and patient interviews. Consensus was established via a three-round Delphi process using a 9-point Likert scale based on how important they felt it was in determining treatment success culminating in a final consensus meeting. Stakeholders were recruited nationally and grouped into three panels (surgeons and radiologists, gastroenterologists and IBD specialist nurses, and patients). Participants received feedback from their panel (in the second round) and all participants (in the third round) to allow refinement of their scores.ResultsA total of 295 outcomes were identified from systematic reviews and interviews that were categorised into 92 domains. 187 stakeholders (response rate 78.5%) prioritised 49 outcomes through a three-round Delphi study. The final consensus meeting of 41 experts and patients generated agreement on an eight domain COS. The COS comprised three patient-reported outcome domains (quality of life, incontinence and a combined score of patient priorities) and five clinician-reported outcome domains (perianal disease activity, development of new perianal abscess/sepsis, new/recurrent fistula, unplanned surgery and faecal diversion).ConclusionA fistulising pCD COS has been produced by all key stakeholders. Application of the COS will reduce heterogeneity in outcome reporting, thereby facilitating more meaningful comparisons between treatments, data synthesis and ultimately benefit patient care.
- Published
- 2018
13. O18 IBD care in 2020: results from the first IBD UK patient and service benchmarking tool
- Author
-
Kapasi, R, primary, Glatter, J, additional, Winsor, G, additional, Parekh, AH, additional, Bassil, S, additional, Clifford, J, additional, Berry, S, additional, Ainley, R, additional, Andrews, C, additional, Bell, G, additional, Bhatnagar, G, additional, Blackwell, J, additional, Bloom, S, additional, Bramwell, C, additional, Brookes, M, additional, Brown, SR, additional, Burch, N, additional, Burman, A, additional, Crook, K, additional, Cummings, F, additional, Dobson, L, additional, Epstein, J, additional, Faiz, O, additional, Feakins, R, additional, Fletcher, M, additional, Garrick, V, additional, Hayee, B, additional, Keetarut, K, additional, Meade, U, additional, Muhammed, R, additional, Murdock, A, additional, Posford, N, additional, Rowse, G, additional, Sagar, P, additional, Segal, J, additional, Selinger, C, additional, St Clair-Jones, A, additional, Taylor, SA, additional, Weaver, S, additional, Younge, L, additional, Barrett, K, additional, Arnott, Ian, additional, Hawthorne, AB, additional, and Lamb, CA, additional
- Published
- 2021
- Full Text
- View/download PDF
14. Transcriptional control of visual neural circuit development by GS homeobox 1.
- Author
-
Alexandra R Schmidt, Haiden J Placer, Ishmael M Muhammad, Rebekah Shephard, Regina L Patrick, Taylor Saurborn, Eric J Horstick, and Sadie A Bergeron
- Subjects
Genetics ,QH426-470 - Abstract
As essential components of gene expression networks, transcription factors regulate neural circuit assembly. The homeobox transcription factor encoding gene, gs homeobox 1 (gsx1), is expressed in the developing visual system; however, no studies have examined its role in visual system formation. In zebrafish, retinal ganglion cell (RGC) axons that transmit visual information to the brain terminate in ten arborization fields (AFs) in the optic tectum (TeO), pretectum (Pr), and thalamus. Pretectal AFs (AF1-AF9) mediate distinct visual behaviors, yet we understand less about their development compared to AF10 in the TeO. Using gsx1 zebrafish mutants, immunohistochemistry, and transgenic lines, we observed that gsx1 is required for vesicular glutamate transporter, Tg(slc17a6b:DsRed), expression in the Pr, but not overall neuron number. gsx1 mutants have normal eye morphology, yet they exhibit impaired visual ability during prey capture. RGC axon volume in the gsx1 mutant Pr and TeO is reduced, and AF7 that is active during feeding is missing which is consistent with reduced hunting performance. Timed laser ablation of Tg(slc17a6b:DsRed)-positive cells reveals that they are necessary for AF7 formation. This work is the first to implicate gsx1 in establishing cell identity and functional neural circuits in the visual system.
- Published
- 2024
- Full Text
- View/download PDF
15. Real‐world multiple myeloma front‐line treatment and outcomes by transplant in the United States
- Author
-
Joshua Richter, Darren Pan, Taylor Salinardi, and Megan S. Rice
- Subjects
multiple myeloma ,real world ,transplant ,Diseases of the blood and blood-forming organs ,RC633-647.5 - Abstract
Abstract Stem cell transplantation (SCT) has been an integral treatment modality for multiple myeloma (MM) for decades. However, as standard‐of‐care therapies have improved, the benefit of SCT has been repeatedly called into question. This retrospective study evaluated the association between SCT in the first line of therapy (LOT) and outcomes for patients with newly diagnosed multiple myeloma (NDMM) in the United States. We included patients from a de‐identified electronic health record‐derived database who initiated front‐line MM therapy between January 1, 2016, and January 31, 2022. Overall, 18.8% (1127 of 5996 patients) received SCT in the first LOT. Multivariable‐adjusted Cox proportional hazards models, in which SCT was modeled as time varying, revealed longer real‐world progression‐free survival (rwPFS; hazard ratio [HR] 0.49; 95% confidence interval [CI] 0.43–0.57) and real‐world overall survival (rwOS; HR 0.47; 95% CI 0.39–0.56) for patients who received SCT in the first LOT. The degree of rwPFS and rwOS benefit imparted by SCT was consistent across all subgroups examined, including patients aged ≥75 years, women, non‐Hispanic Black/African American patients, those with renal impairment, and those with high‐risk cytogenetics. Findings from this analysis of real‐world patients with NDMM suggest that SCT remains an important standard of care in the era of novel therapies.
- Published
- 2023
- Full Text
- View/download PDF
16. Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment
- Author
-
Miles, A, Taylor, SA, Evans, REC, Halligan, S, Beare, S, Bridgewater, J, Goh, V, Janes, S, Navani, N, Oliver, A, Morton, A, Rockall, A, Clarke, CS, Morris, S, Aboagye, A, Agoramoorthy, L, Ahmed, S, Amadi, A, Anand, G, Atkin, G, Austria, A, Ball, S, Bazari, F, Beable, R, Beedham, H, Beeston, T, Bharwani, N, Bhatnagar, G, Bhowmik, A, Blakeway, L, Blunt, D, Boavida, P, Boisfer, D, Breen, D, Burke, S, Butawan, R, Campbell, Y, Chang, E, Chao, D, Chukundah, S, Collins, B, Collins, C, Conteh, V, Couture, J, Crosbie, J, Curtis, H, Daniel, A, Davis, L, Desai, K, Duggan, M, Ellis, S, Elton, C, Engledow, A, Everitt, C, Ferdous, S, Frow, A, Furneaux, M, Gibbons, N, Glynne-Jones, R, Gogbashian, A, Gourtsoyianni, S, Green, A, Green, L, Groves, A, Guthrie, A, Hadley, E, Hameeduddin, A, Hanid, G, Hans, S, Hans, B, Higginson, A, Honeyfield, L, Hughes, H, Hughes, J, Hurl, L, Isaac, E, Jackson, M, Jalloh, A, Jannapureddy, R, Jayme, A, Johnson, A, Johnson, E, Julka, P, Kalasthry, J, Karapanagiotou, E, Karp, S, Kay, C, Kellaway, J, Khan, S, Koh, D-M, Light, T, Limbu, P, Lock, S, Locke, I, Loke, T, Lowe, A, Lucas, N, Maheswaran, S, Mallett, S, Marwood, E, McGowan, J, Mckirdy, F, Mills-Baldock, T, Moon, T, Morgan, V, Nasseri, S, Nichols, P, Norman, C, Ntala, E, Nunes, A, Obichere, A, O'Donohue, J, Olaleye, I, Onajobi, A, O'Shaughnessy, T, Padhani, A, Pardoe, H, Partridge, W, Patel, U, Perry, K, Piga, W, Prezzi, D, Prior, K, Punwani, S, Pyers, J, Rafiee, H, Rahman, F, Rajanpandian, I, Ramesh, S, Raouf, S, Reczko, K, Reinhardt, A, Robinson, D, Russell, P, Sargus, K, Scurr, E, Shahabuddin, K, Sharp, A, Shepherd, B, Shiu, K, Sidhu, H, Simcock, I, Simeon, C, Smith, A, Smith, D, Snell, D, Spence, J, Srirajaskanthan, R, Stachini, V, Stegner, S, Stirling, J, Strickland, N, Tarver, K, Teague, J, Thaha, M, Train, M, Tulmuntaha, S, Tunariu, N, Van Ree, K, Verjee, A, Wanstall, C, Weir, S, Wijeyekoon, S, Wilson, J, Wilson, S, Win, T, Woodrow, L, Yu, D, Imperial College Healthcare NHS Trust- BRC Funding, and Department of Health
- Subjects
Adult ,Male ,Positron emission tomography ,Lung Neoplasms ,Social Sciences ,X-ray computed ,Magnetic resonance imaging ,Psychology, Multidisciplinary ,Positron Emission Tomography Computed Tomography ,Surveys and Questionnaires ,Psychology ,Humans ,Whole Body Imaging ,Patient preference ,Prospective Studies ,Tomography ,Cancer ,Aged ,Neoplasm Staging ,Science & Technology ,Radiology, Nuclear Medicine & Medical Imaging ,Tomography, X-ray computed ,1103 Clinical Sciences ,CARE ,Middle Aged ,NEGATIVE AFFECT ,Biomedical Social Sciences ,Social Sciences, Biomedical ,Nuclear Medicine & Medical Imaging ,PANAS ,Oncology ,Positron-Emission Tomography ,Regression Analysis ,CLAUSTROPHOBIA ,Female ,STREAMLINE investigators ,Colorectal Neoplasms ,Life Sciences & Biomedicine - Abstract
Objectives To determine the importance placed by patients on attributes associated with whole-body MRI (WB-MRI) and standard cancer staging pathways and ascertain drivers of preference. Methods Patients recruited to two multi-centre diagnostic accuracy trials comparing WB-MRI with standard staging pathways in lung and colorectal cancer were invited to complete a discrete choice experiment (DCE), choosing between a series of alternate pathways in which 6 attributes (accuracy, time to diagnosis, scan duration, whole-body enclosure, radiation exposure, total scan number) were varied systematically. Data were analysed using a conditional logit regression model and marginal rates of substitution computed. The relative importance of each attribute and probabilities of choosing WB-MRI-based pathways were estimated. Results A total of 138 patients (mean age 65, 61% male, lung n = 72, colorectal n = 66) participated (May 2015 to September 2016). Lung cancer patients valued time to diagnosis most highly, followed by accuracy, radiation exposure, number of scans, and time in the scanner. Colorectal cancer patients valued accuracy most highly, followed by time to diagnosis, radiation exposure, and number of scans. Patients were willing to wait 0.29 (lung) and 0.45 (colorectal) weeks for a 1% increase in pathway accuracy. Patients preferred WB-MRI-based pathways (probability 0.64 [lung], 0.66 [colorectal]) if they were equivalent in accuracy, total scan number, and time to diagnosis compared with a standard staging pathway. Conclusions Staging pathways based on first-line WB-MRI are preferred by the majority of patients if they at least match standard pathways for diagnostic accuracy, time to diagnosis, and total scan number.
- Published
- 2019
17. Magnetic resonance enterography, small bowel ultrasound and colonoscopy to diagnose and stage Crohn's disease: patient acceptability and perceived burden
- Author
-
Miles, A, Bhatnagar, G, Halligan, S, Gupta, A, Tolan, D, Zealley, I, Taylor, SA, and METRIC investigators
- Abstract
OBJECTIVES: To compare patient acceptability and burden of magnetic resonance enterography (MRE) and ultrasound (US) to each other, and to other enteric investigations, particularly colonoscopy. METHODS: 159 patients (mean age 38, 94 female) with newly diagnosed or relapsing Crohn's disease, prospectively recruited to a multicentre diagnostic accuracy study comparing MRE and US completed an experience questionnaire on the burden and acceptability of small bowel investigations between December 2013 and September 2016. Acceptability, recovery time, scan burden and willingness to repeat the test were analysed using the Wilcoxon signed rank and McNemar tests; and group differences in scan burden with Mann-Whitney U and Kruskal-Wallis tests. RESULTS: Overall, 128 (88%) patients rated MRE as very or fairly acceptable, lower than US (144, 99%; p < 0.001), but greater than colonoscopy (60, 60%; p < 0.001). MRE recovery time was longer than US (p < 0.001), but shorter than colonoscopy (p < 0.001). Patients were less willing to undergo MRE again than US (127 vs. 133, 91% vs. 99%; p = 0.012), but more willing than for colonoscopy (68, 75%; p = 0.017). MRE generated greater burden than US (p < 0.001), although burden scores were low. Younger age and emotional distress were associated with greater MRE and US burden. Higher MRE discomfort was associated with patient preference for US (p = 0.053). Patients rated test accuracy as more important than scan discomfort. CONCLUSIONS: MRE and US are well tolerated. Although MRE generates greater burden, longer recovery and is less preferred than US, it is more acceptable than colonoscopy. Patients, however, place greater emphasis on diagnostic accuracy than burden. KEY POINTS: • MRE and US are rated as acceptable by most patients and superior to colonoscopy. • MRE generates significantly greater burden and longer recovery times than US, particularly in younger patients and those with high levels of emotional distress. • Most patients prefer the experience of undergoing US than MRE; however, patients rate test accuracy as more importance than scan burden.
- Published
- 2019
18. Increasing Realism and Variety of Virtual Patient Dialogues for Prenatal Counseling Education Through a Novel Application of ChatGPT: Exploratory Observational Study
- Author
-
Megan Gray, Austin Baird, Taylor Sawyer, Jasmine James, Thea DeBroux, Michelle Bartlett, Jeanne Krick, and Rachel Umoren
- Subjects
Special aspects of education ,LC8-6691 ,Medicine (General) ,R5-920 - Abstract
BackgroundUsing virtual patients, facilitated by natural language processing, provides a valuable educational experience for learners. Generating a large, varied sample of realistic and appropriate responses for virtual patients is challenging. Artificial intelligence (AI) programs can be a viable source for these responses, but their utility for this purpose has not been explored. ObjectiveIn this study, we explored the effectiveness of generative AI (ChatGPT) in developing realistic virtual standardized patient dialogues to teach prenatal counseling skills. MethodsChatGPT was prompted to generate a list of common areas of concern and questions that families expecting preterm delivery at 24 weeks gestation might ask during prenatal counseling. ChatGPT was then prompted to generate 2 role-plays with dialogues between a parent expecting a potential preterm delivery at 24 weeks and their counseling physician using each of the example questions. The prompt was repeated for 2 unique role-plays: one parent was characterized as anxious and the other as having low trust in the medical system. Role-play scripts were exported verbatim and independently reviewed by 2 neonatologists with experience in prenatal counseling, using a scale of 1-5 on realism, appropriateness, and utility for virtual standardized patient responses. ResultsChatGPT generated 7 areas of concern, with 35 example questions used to generate role-plays. The 35 role-play transcripts generated 176 unique parent responses (median 5, IQR 4-6, per role-play) with 268 unique sentences. Expert review identified 117 (65%) of the 176 responses as indicating an emotion, either directly or indirectly. Approximately half (98/176, 56%) of the responses had 2 or more sentences, and half (88/176, 50%) included at least 1 question. More than half (104/176, 58%) of the responses from role-played parent characters described a feeling, such as being scared, worried, or concerned. The role-plays of parents with low trust in the medical system generated many unique sentences (n=50). Most of the sentences in the responses were found to be reasonably realistic (214/268, 80%), appropriate for variable prenatal counseling conversation paths (233/268, 87%), and usable without more than a minimal modification in a virtual patient program (169/268, 63%). ConclusionsGenerative AI programs, such as ChatGPT, may provide a viable source of training materials to expand virtual patient programs, with careful attention to the concerns and questions of patients and families. Given the potential for unrealistic or inappropriate statements and questions, an expert should review AI chat outputs before deploying them in an educational program.
- Published
- 2024
- Full Text
- View/download PDF
19. Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trial
- Author
-
Taylor, SA, Mallett, S, Bhatnagar, G, Baldwin-Cleland, R, Bloom, S, Gupta, A, Hamlin, PJ, Hart, AL, Higginson, A, Jacobs, I, McCartney, S, Miles, A, Murray, CD, Plumb, AA, Pollok, RC, Punwani, S, Quinn, L, Rodriguez-Justo, M, Shabir, Z, Slater, A, Tolan, D, Travis, S, Windsor, A, Wylie, P, Zealley, I, Halligan, S, and METRIC study investigators
- Abstract
BACKGROUND: Magnetic resonance enterography (MRE) and ultrasound are used to image Crohn's disease, but their comparative accuracy for assessing disease extent and activity is not known with certainty. Therefore, we did a multicentre trial to address this issue. METHODS: We recruited patients from eight UK hospitals. Eligible patients were 16 years or older, with newly diagnosed Crohn's disease or with established disease and suspected relapse. Consecutive patients had MRE and ultrasound in addition to standard investigations. Discrepancy between MRE and ultrasound for the presence of small bowel disease triggered an additional investigation, if not already available. The primary outcome was difference in per-patient sensitivity for small bowel disease extent (correct identification and segmental localisation) against a construct reference standard (panel diagnosis). This trial is registered with the International Standard Randomised Controlled Trial, number ISRCTN03982913, and has been completed. FINDINGS: 284 patients completed the trial (133 in the newly diagnosed group, 151 in the relapse group). Based on the reference standard, 233 (82%) patients had small bowel Crohn's disease. The sensitivity of MRE for small bowel disease extent (80% [95% CI 72-86]) and presence (97% [91-99]) were significantly greater than that of ultrasound (70% [62-78] for disease extent, 92% [84-96] for disease presence); a 10% (95% CI 1-18; p=0·027) difference for extent, and 5% (1-9; p=0·025) difference for presence. The specificity of MRE for small bowel disease extent (95% [85-98]) was significantly greater than that of ultrasound (81% [64-91]); a difference of 14% (1-27; p=0·039). The specificity for small bowel disease presence was 96% (95% CI 86-99) with MRE and 84% (65-94) with ultrasound (difference 12% [0-25]; p=0·054). There were no serious adverse events. INTERPRETATION: Both MRE and ultrasound have high sensitivity for detecting small bowel disease presence and both are valid first-line investigations, and viable alternatives to ileocolonoscopy. However, in a national health service setting, MRE is generally the preferred radiological investigation when available because its sensitivity and specificity exceed ultrasound significantly. FUNDING: National Institute of Health and Research Health Technology Assessment.
- Published
- 2018
20. Influence of Spatter on Porosity, Microstructure, and Corrosion of Additively Manufactured Stainless Steel Printed Using Different Island Size
- Author
-
Venkata Bhuvaneswari Vukkum, Taylor Sanborn, John Shepherd, Sourabh Saptarshi, Rakesh Basu, Timothy Horn, and Rajeev Kumar Gupta
- Subjects
additive manufacturing ,laser powder bed fusion ,stainless steel ,microstructure ,corrosion ,Crystallography ,QD901-999 - Abstract
Specimens of 316 L stainless steel were printed using laser powder bed fusion (LPBF), a popular metal additive manufacturing (AM) technique, with varying island sizes. Not many researchers have considered the impact of spatter while optimizing LPBF printing parameters. In this research, the influence of spatter was considered while also investigating the effect of varied island size on the microstructure, surface roughness, microhardness, and corrosion resistance of LPBF-316 L. No correlation was observed between surface roughness or microhardness and minor variations in island size. However, a correlation was drawn between varied island sizes and porosity in LPBF-316 L. The specimens associated with larger island sizes showed significantly enhanced corrosion resistance due to fewer manufacturing defects and reduced porosity, attributed to the minimal influence of the spatter. Based on analysis, the LPBF parameters were revised, which lead to superior corrosion resistance of LPBF-316 L, attributed to high density and reduced porosity.
- Published
- 2024
- Full Text
- View/download PDF
21. LRRK2 G2019S Promotes Colon Cancer Potentially via LRRK2–GSDMD Axis-Mediated Gut Inflammation
- Author
-
Yuhang Wang, Joyce Z. Gao, Taylor Sakaguchi, Thorsten Maretzky, Prajwal Gurung, Nandakumar S. Narayanan, Sarah Short, Yiqin Xiong, and Zizhen Kang
- Subjects
LRRK2 G2019S ,colitis ,colon cancer ,inflammation ,Cytology ,QH573-671 - Abstract
Leucine-rich repeat kinase 2 (LRRK2) is a serine–threonine protein kinase belonging to the ROCO protein family. Within the kinase domain of LRRK2, a point mutation known as LRRK2 G2019S has emerged as the most prevalent variant associated with Parkinson’s disease. Recent clinical studies have indicated that G2019S carriers have an elevated risk of cancers, including colon cancer. Despite this observation, the underlying mechanisms linking LRRK2 G2019S to colon cancer remain elusive. In this study, employing a colitis-associated cancer (CAC) model and LRRK2 G2019S knock-in (KI) mouse model, we demonstrate that LRRK2 G2019S promotes the pathogenesis of colon cancer, characterized by increased tumor number and size in KI mice. Furthermore, LRRK2 G2019S enhances intestinal epithelial cell proliferation and inflammation within the tumor microenvironment. Mechanistically, KI mice exhibit heightened susceptibility to DSS-induced colitis, with inhibition of LRRK2 kinase activity ameliorating colitis severity and CAC progression. Our investigation also reveals that LRRK2 G2019S promotes inflammasome activation and exacerbates gut epithelium necrosis in the colitis model. Notably, GSDMD inhibitors attenuate colitis in LRRK2 G2019S KI mice. Taken together, our findings offer experimental evidence indicating that the gain-of-kinase activity in LRRK2 promotes colorectal tumorigenesis, suggesting LRRK2 as a potential therapeutic target in colon cancer patients exhibiting hyper LRRK2 kinase activity.
- Published
- 2024
- Full Text
- View/download PDF
22. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting
- Author
-
Beets-Tan, RGH, Lambregts, DMJ, Maas, M, Bipat, S, Barbaro, B, Curvo-Semedo, L, Fenlon, HM, Gollub, MJ, Gourtsoyianni, S, Halligan, S, Hoeffel, C, Kim, SH, Laghi, A, Maier, A, Rafaelsen, SR, Stoker, J, Taylor, SA, Torkzad, MR, Blomqvist, L, Beets-Tan, RGH, Lambregts, DMJ, Maas, M, Bipat, S, Barbaro, B, Curvo-Semedo, L, Fenlon, HM, Gollub, MJ, Gourtsoyianni, S, Halligan, S, Hoeffel, C, Kim, SH, Laghi, A, Maier, A, Rafaelsen, SR, Stoker, J, Taylor, SA, Torkzad, MR, and Blomqvist, L
- Abstract
OBJECTIVES: To update the 2012 ESGAR consensus guidelines on the acquisition, interpretation and reporting of magnetic resonance imaging (MRI) for clinical staging and restaging of rectal cancer. METHODS: Fourteen abdominal imaging experts from the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) participated in a consensus meeting, organised according to an adaptation of the RAND-UCLA Appropriateness Method. Two independent (non-voting) Chairs facilitated the meeting. 246 items were scored (comprising 229 items from the previous 2012 consensus and 17 additional items) and classified as 'appropriate' or 'inappropriate' (defined by ≥ 80 % consensus) or uncertain (defined by < 80 % consensus). RESULTS: Consensus was reached for 226 (92 %) of items. From these recommendations regarding hardware, patient preparation, imaging sequences and acquisition, criteria for MR imaging evaluation and reporting structure were constructed. The main additions to the 2012 consensus include recommendations regarding use of diffusion-weighted imaging, criteria for nodal staging and a recommended structured report template. CONCLUSIONS: These updated expert consensus recommendations should be used as clinical guidelines for primary staging and restaging of rectal cancer using MRI. KEY POINTS: • These guidelines present recommendations for staging and reporting of rectal cancer. • The guidelines were constructed through consensus amongst 14 pelvic imaging experts. • Consensus was reached by the experts for 92 % of the 246 items discussed. • Practical guidelines for nodal staging are proposed. • A structured reporting template is presented.
- Published
- 2018
23. Real-world multiple myeloma risk factors and outcomes by non-Hispanic Black/African American and non- Hispanic White race/ethnicity in the United States
- Author
-
Tondre Buck, Monique A. Hartley-Brown, Yvonne A. Efebera, Carter P. Milner, Jeffrey A. Zonder, Paul G. Richardson, Taylor Salinardi, and Megan S. Rice
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Abstract
Examination of the impact of race and ethnicity on multiple myeloma (MM) outcomes has yielded inconsistent results. This retrospective, real-world (RW) study describes patient, disease, and treatment characteristics (and associations with survival outcomes) among newly diagnosed MM patients of non-Hispanic (NH) Black/African American (AA) and NH White race/ethnicity in the US. We included patients from the nationwide Flatiron Health electronic health record-derived de-identified database who initiated first line of therapy (LOT) for MM between January 1, 2016 and March 31, 2022. Of 4,614 patients in our study cohort, 23.3% were NH Black/AA. Non-Hispanic Black/AA patients were younger than NH White patients at diagnosis (median 68 vs. 71 years) and more likely to be female (53.4% vs. 43.5%). Rates of high-risk cytogenetics and 1q21+ were similar between races/ethnicities. The most common primary regimen used was lenalidomide-bortezomib-dexamethasone (50.1% of NH Black/AA and 48.1% of NH White patients). Receipt of stem cell transplantation during first LOT was less common among NH Black/AA (16.5%) than NH White (21.9%) patients. Unadjusted RW progression-free survival (rwPFS) and overall survival (rwOS) were similar between races/ethnicities. After multivariable adjustment, NH Black/AA race/ethnicity was associated with slightly inferior rwPFS (hazard ratio [HR]=1.13; 95% confidence interval [CI]: 1.01-1.27). The difference in rwOS (HR=1.12; 95% CI: 0.98-1.28) was not statistically significant. In general, associations between risk factors for rwPFS and rwOS were consistent between races/ethnicities. Findings from this analysis help to inform clinicians about the impact of race/ethnicity on MM treatment paradigms and outcomes in the US.
- Published
- 2023
- Full Text
- View/download PDF
24. Erratum to:Methods for evaluating medical tests and biomarkers
- Author
-
Gopalakrishna, G, Langendam, M, Scholten, R, Bossuyt, P, Leeflang, M, Noel-Storr, A, Thomas, J, Marshall, I, Wallace, B, Whiting, P, Davenport, C, GopalaKrishna, G, De Salis, I, Mallett, S, Wolff, R, Riley, R, Westwood, M, Kleinen, J, Collins, G, Reitsma, H, Moons, K, Zapf, A, Hoyer, A, Kramer, K, Kuss, O, Ensor, J, Deeks, JJ, Martin, EC, Riley, RD, Rücker, G, Steinhauser, S, Schumacher, M, Snell, K, Willis, B, Debray, T, Deeks, J, Di Ruffano, LF, Taylor-Phillips, S, Hyde, C, Taylor, SA, Batnagar, G, STREAMLINE COLON Investigators, STREAMLINE LUNG Investigators, METRIC Investigators, Seedat, F, Clarke, A, Byron, S, Nixon, F, Albrow, R, Walker, T, Deakin, C, Zhelev, Z, Hunt, H, Yang, Y, Abel, L, Buchanan, J, Fanshawe, T, Shinkins, B, Wynants, L, Verbakel, J, Van Huffel, S, Timmerman, D, Van Calster, B, Zwinderman, A, Oke, J, O'Sullivan, J, Perera, R, Nicholson, B, Bromley, HL, Roberts, TE, Francis, A, Petrie, D, Mann, GB, Malottki, K, Smith, H, Billingham, L, Sitch, A, Gerke, O, Holm-Vilstrup, M, Segtnan, EA, Halekoh, U, Høilund-Carlsen, PF, Francq, BG, Dinnes, J, Parkes, J, Gregory, W, Hewison, J, Altman, D, Rosenberg, W, Selby, P, Asselineau, J, Perez, P, Paye, A, Bessede, E, Proust-Lima, C, Naaktgeboren, C, De Groot, J, Rutjes, A, Reitsma, J, Ogundimu, E, Cook, J, Le Manach, Y, Vergouwe, Y, Pajouheshnia, R, Groenwold, R, Peelen, L, Nieboer, D, De Cock, B, Pencina, MJ, Steyerberg, EW, Cooper, J, Parsons, N, Stinton, C, Smith, S, Dickens, A, Jordan, R, Enocson, A, Fitzmaurice, D, Adab, P, Boachie, C, Vidmar, G, Freeman, K, Connock, M, Court, R, Moons, C, Harris, J, Mumford, A, Plummer, Z, Lee, K, Reeves, B, Rogers, C, Verheyden, V, Angelini, GD, Murphy, GJ, Huddy, J, Ni, M, Good, K, Cooke, G, Hanna, G, Ma, J, Moons, KGMC, De Groot, JAH, Altman, DG, Reitsma, JB, Collins, GS, Moons, KGM, Kamarudin, AN, Kolamunnage-Dona, R, Cox, T, Borsci, S, Pérez, T, Pardo, MC, Candela-Toha, A, Muriel, A, Zamora, J, Sanghera, S, Mohiuddin, S, Martin, R, Donovan, J, Coast, J, Seo, MK, Cairns, J, Mitchell, E, Smith, A, Wright, J, Hall, P, Messenger, M, Calder, N, Wickramasekera, N, Vinall-Collier, K, Lewington, A, Damen, J, Cairns, D, Hutchinson, M, Sturgeon, C, Mitchel, L, Kift, R, Christakoudi, S, Rungall, M, Mobillo, P, Montero, R, Tsui, T-L, Kon, SP, Tucker, B, Sacks, S, Farmer, C, Strom, T, Chowdhury, P, Rebollo-Mesa, I, Hernandez-Fuentes, M, Damen, JAAG, Debray, TPA, Heus, P, Hooft, L, Scholten, RJPM, Schuit, E, Tzoulaki, I, Lassale, CM, Siontis, GCM, Chiocchia, V, Roberts, C, Schlüssel, MM, Gerry, S, Black, JA, Van der Schouw, YT, Peelen, LM, Spence, G, McCartney, D, Van den Bruel, A, Lasserson, D, Hayward, G, Vach, W, De Jong, A, Burggraaff, C, Hoekstra, O, Zijlstra, J, De Vet, H, Graziadio, S, Allen, J, Johnston, L, O'Leary, R, Power, M, Johnson, L, Waters, R, Simpson, J, Fanshawe, TR, Phillips, P, Plumb, A, Helbren, E, Halligan, S, Gale, A, Sekula, P, Sauerbrei, W, Forman, JR, Dutton, SJ, Takwoingi, Y, Hensor, EM, Nichols, TE, Kempf, E, Porcher, R, De Beyer, J, Hopewell, S, Dennis, J, Shields, B, Jones, A, Henley, W, Pearson, E, Hattersley, A, MASTERMIND consortium, Scheibler, F, Rummer, A, Sturtz, S, Großelfinger, R, Banister, K, Ramsay, C, Azuara-Blanco, A, Burr, J, Kumarasamy, M, Bourne, R, Uchegbu, I, Murphy, J, Carter, A, Marti, J, Eatock, J, Robotham, J, Dudareva, M, Gilchrist, M, Holmes, A, Monaghan, P, Lord, S, StJohn, A, Sandberg, S, Cobbaert, C, Lennartz, L, Verhagen-Kamerbeek, W, Ebert, C, Horvath, A, Test Evaluation Working Group of the European Federation of Clinical Chemistry and Laboratory Medicine, Jenniskens, K, Peters, J, Grigore, B, Ukoumunne, O, Levis, B, Benedetti, A, Levis, AW, Ioannidis, JPA, Shrier, I, Cuijpers, P, Gilbody, S, Kloda, LA, McMillan, D, Patten, SB, Steele, RJ, Ziegelstein, RC, Bombardier, CH, Osório, FDL, Fann, JR, Gjerdingen, D, Lamers, F, Lotrakul, M, Loureiro, SR, Löwe, B, Shaaban, J, Stafford, L, Van Weert, HCPM, Whooley, MA, Williams, LS, Wittkampf, KA, Yeung, AS, Thombs, BD, Cooper, C, Nieto, T, Smith, C, Tucker, O, Dretzke, J, Beggs, A, Rai, N, Bayliss, S, Stevens, S, Mallet, S, Sundar, S, Hall, E, Porta, N, Estelles, DL, De Bono, J, CTC-STOP protocol development group, and National Institute for Health Research
- Subjects
medicine.medical_specialty ,Astrophysics::High Energy Astrophysical Phenomena ,MEDLINE ,030204 cardiovascular system & hematology ,BTC (Bristol Trials Centre) ,MASTERMIND consortium ,03 medical and health sciences ,0302 clinical medicine ,medicine ,030212 general & internal medicine ,Intensive care medicine ,CTC-STOP protocol development group ,lcsh:R5-920 ,business.industry ,Test Evaluation Working Group of the European Federation of Clinical Chemistry and Laboratory Medicine ,Published Erratum ,STREAMLINE COLON Investigators ,3. Good health ,STREAMLINE LUNG Investigators ,Centre for Surgical Research ,Family medicine ,METRIC Investigators ,High Energy Physics::Experiment ,Erratum ,business ,lcsh:Medicine (General) - Abstract
[This corrects the article DOI: 10.1186/s41512-016-0001-y.].
- Published
- 2017
25. Extended functional connectivity of convergent structural alterations among individuals with PTSD: a neuroimaging meta-analysis
- Author
-
Brianna S. Pankey, Michael C. Riedel, Isis Cowan, Jessica E. Bartley, Rosario Pintos Lobo, Lauren D. Hill-Bowen, Taylor Salo, Erica D. Musser, Matthew T. Sutherland, and Angela R. Laird
- Subjects
Post-traumatic stress disorder ,Meta-analysis ,Voxel-based morphometry ,Functional connectivity ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Abstract Background Post-traumatic stress disorder (PTSD) is a debilitating disorder defined by the onset of intrusive, avoidant, negative cognitive or affective, and/or hyperarousal symptoms after witnessing or experiencing a traumatic event. Previous voxel-based morphometry studies have provided insight into structural brain alterations associated with PTSD with notable heterogeneity across these studies. Furthermore, how structural alterations may be associated with brain function, as measured by task-free and task-based functional connectivity, remains to be elucidated. Methods Using emergent meta-analytic techniques, we sought to first identify a consensus of structural alterations in PTSD using the anatomical likelihood estimation (ALE) approach. Next, we generated functional profiles of identified convergent structural regions utilizing resting-state functional connectivity (rsFC) and meta-analytic co-activation modeling (MACM) methods. Finally, we performed functional decoding to examine mental functions associated with our ALE, rsFC, and MACM brain characterizations. Results We observed convergent structural alterations in a single region located in the medial prefrontal cortex. The resultant rsFC and MACM maps identified functional connectivity across a widespread, whole-brain network that included frontoparietal and limbic regions. Functional decoding revealed overlapping associations with attention, memory, and emotion processes. Conclusions Consensus-based functional connectivity was observed in regions of the default mode, salience, and central executive networks, which play a role in the tripartite model of psychopathology. Taken together, these findings have important implications for understanding the neurobiological mechanisms associated with PTSD.
- Published
- 2022
- Full Text
- View/download PDF
26. Erratum to: Methods for evaluating medical tests and biomarkers.
- Author
-
Gopalakrishna, G, Langendam, M, Scholten, R, Bossuyt, P, Leeflang, M, Noel-Storr, A, Thomas, J, Marshall, I, Wallace, B, Whiting, P, Davenport, C, GopalaKrishna, G, de Salis, I, Mallett, S, Wolff, R, Riley, R, Westwood, M, Kleinen, J, Collins, G, Reitsma, H, Moons, K, Zapf, A, Hoyer, A, Kramer, K, Kuss, O, Ensor, J, Deeks, JJ, Martin, EC, Riley, RD, Rücker, G, Steinhauser, S, Schumacher, M, Snell, K, Willis, B, Debray, T, Deeks, J, di Ruffano, LF, Taylor-Phillips, S, Hyde, C, Taylor, SA, Batnagar, G, STREAMLINE COLON Investigators, STREAMLINE LUNG Investigators, METRIC Investigators, Di Ruffano, LF, Seedat, F, Clarke, A, Byron, S, Nixon, F, Albrow, R, Walker, T, Deakin, C, Zhelev, Z, Hunt, H, Yang, Y, Abel, L, Buchanan, J, Fanshawe, T, Shinkins, B, Wynants, L, Verbakel, J, Van Huffel, S, Timmerman, D, Van Calster, B, Zwinderman, A, Oke, J, O'Sullivan, J, Perera, R, Nicholson, B, Bromley, HL, Roberts, TE, Francis, A, Petrie, D, Mann, GB, Malottki, K, Smith, H, Billingham, L, Sitch, A, Gerke, O, Holm-Vilstrup, M, Segtnan, EA, Halekoh, U, Høilund-Carlsen, PF, Francq, BG, Dinnes, J, Parkes, J, Gregory, W, Hewison, J, Altman, D, Rosenberg, W, Selby, P, Asselineau, J, Perez, P, Paye, A, Bessede, E, Proust-Lima, C, Naaktgeboren, C, de Groot, J, Rutjes, A, Reitsma, J, Ogundimu, E, Cook, J, Le Manach, Y, Vergouwe, Y, Pajouheshnia, R, Groenwold, R, Peelen, L, Nieboer, D, De Cock, B, Pencina, MJ, Steyerberg, EW, Cooper, J, Parsons, N, Stinton, C, Smith, S, Dickens, A, Jordan, R, Enocson, A, Fitzmaurice, D, Adab, P, Boachie, C, Vidmar, G, Freeman, K, Connock, M, Court, R, Moons, C, Harris, J, Mumford, A, Plummer, Z, Lee, K, Reeves, B, Rogers, C, Verheyden, V, Angelini, GD, Murphy, GJ, Huddy, J, Ni, M, Good, K, Cooke, G, Hanna, G, Ma, J, Moons, KGMC, de Groot, JAH, Altman, DG, Reitsma, JB, Collins, GS, Moons, KGM, Kamarudin, AN, Kolamunnage-Dona, R, Cox, T, Borsci, S, Pérez, T, Pardo, MC, Candela-Toha, A, Muriel, A, Zamora, J, Sanghera, S, Mohiuddin, S, Martin, R, Donovan, J, Coast, J, Seo, MK, Cairns, J, Mitchell, E, Smith, A, Wright, J, Hall, P, Messenger, M, Calder, N, Wickramasekera, N, Vinall-Collier, K, Lewington, A, Damen, J, Cairns, D, Hutchinson, M, Sturgeon, C, Mitchel, L, Kift, R, Christakoudi, S, Rungall, M, Mobillo, P, Montero, R, Tsui, T-L, Kon, SP, Tucker, B, Sacks, S, Farmer, C, Strom, T, Chowdhury, P, Rebollo-Mesa, I, Hernandez-Fuentes, M, Damen, JAAG, Debray, TPA, Heus, P, Hooft, L, Scholten, RJPM, Schuit, E, Tzoulaki, I, Lassale, CM, Siontis, GCM, Chiocchia, V, Roberts, C, Schlüssel, MM, Gerry, S, Black, JA, van der Schouw, YT, Peelen, LM, Spence, G, McCartney, D, van den Bruel, A, Lasserson, D, Hayward, G, Vach, W, de Jong, A, Burggraaff, C, Hoekstra, O, Zijlstra, J, de Vet, H, Graziadio, S, Allen, J, Johnston, L, O'Leary, R, Power, M, Johnson, L, Waters, R, Simpson, J, Fanshawe, TR, Phillips, P, Plumb, A, Helbren, E, Halligan, S, Gale, A, Sekula, P, Sauerbrei, W, Forman, JR, Dutton, SJ, Takwoingi, Y, Hensor, EM, Nichols, TE, Kempf, E, Porcher, R, de Beyer, J, Hopewell, S, Dennis, J, Shields, B, Jones, A, Henley, W, Pearson, E, Hattersley, A, MASTERMIND consortium, Scheibler, F, Rummer, A, Sturtz, S, Großelfinger, R, Banister, K, Ramsay, C, Azuara-Blanco, A, Burr, J, Kumarasamy, M, Bourne, R, Uchegbu, I, Murphy, J, Carter, A, Marti, J, Eatock, J, Robotham, J, Dudareva, M, Gilchrist, M, Holmes, A, Monaghan, P, Lord, S, StJohn, A, Sandberg, S, Cobbaert, C, Lennartz, L, Verhagen-Kamerbeek, W, Ebert, C, Horvath, A, Test Evaluation Working Group of the European Federation of Clinical Chemistry and Laboratory Medicine, Jenniskens, K, Peters, J, Grigore, B, Ukoumunne, O, Levis, B, Benedetti, A, Levis, AW, Ioannidis, JPA, Shrier, I, Cuijpers, P, Gilbody, S, Kloda, LA, McMillan, D, Patten, SB, Steele, RJ, Ziegelstein, RC, Bombardier, CH, Osório, FDL, Fann, JR, Gjerdingen, D, Lamers, F, Lotrakul, M, Loureiro, SR, Löwe, B, Shaaban, J, Stafford, L, van Weert, HCPM, Whooley, MA, Williams, LS, Wittkampf, KA, Yeung, AS, Thombs, BD, Cooper, C, Nieto, T, Smith, C, Tucker, O, Dretzke, J, Beggs, A, Rai, N, Bayliss, S, Stevens, S, Mallet, S, Sundar, S, Hall, E, Porta, N, Estelles, DL, de Bono, J, CTC-STOP protocol development group, Gopalakrishna, G, Langendam, M, Scholten, R, Bossuyt, P, Leeflang, M, Noel-Storr, A, Thomas, J, Marshall, I, Wallace, B, Whiting, P, Davenport, C, GopalaKrishna, G, de Salis, I, Mallett, S, Wolff, R, Riley, R, Westwood, M, Kleinen, J, Collins, G, Reitsma, H, Moons, K, Zapf, A, Hoyer, A, Kramer, K, Kuss, O, Ensor, J, Deeks, JJ, Martin, EC, Riley, RD, Rücker, G, Steinhauser, S, Schumacher, M, Snell, K, Willis, B, Debray, T, Deeks, J, di Ruffano, LF, Taylor-Phillips, S, Hyde, C, Taylor, SA, Batnagar, G, STREAMLINE COLON Investigators, STREAMLINE LUNG Investigators, METRIC Investigators, Di Ruffano, LF, Seedat, F, Clarke, A, Byron, S, Nixon, F, Albrow, R, Walker, T, Deakin, C, Zhelev, Z, Hunt, H, Yang, Y, Abel, L, Buchanan, J, Fanshawe, T, Shinkins, B, Wynants, L, Verbakel, J, Van Huffel, S, Timmerman, D, Van Calster, B, Zwinderman, A, Oke, J, O'Sullivan, J, Perera, R, Nicholson, B, Bromley, HL, Roberts, TE, Francis, A, Petrie, D, Mann, GB, Malottki, K, Smith, H, Billingham, L, Sitch, A, Gerke, O, Holm-Vilstrup, M, Segtnan, EA, Halekoh, U, Høilund-Carlsen, PF, Francq, BG, Dinnes, J, Parkes, J, Gregory, W, Hewison, J, Altman, D, Rosenberg, W, Selby, P, Asselineau, J, Perez, P, Paye, A, Bessede, E, Proust-Lima, C, Naaktgeboren, C, de Groot, J, Rutjes, A, Reitsma, J, Ogundimu, E, Cook, J, Le Manach, Y, Vergouwe, Y, Pajouheshnia, R, Groenwold, R, Peelen, L, Nieboer, D, De Cock, B, Pencina, MJ, Steyerberg, EW, Cooper, J, Parsons, N, Stinton, C, Smith, S, Dickens, A, Jordan, R, Enocson, A, Fitzmaurice, D, Adab, P, Boachie, C, Vidmar, G, Freeman, K, Connock, M, Court, R, Moons, C, Harris, J, Mumford, A, Plummer, Z, Lee, K, Reeves, B, Rogers, C, Verheyden, V, Angelini, GD, Murphy, GJ, Huddy, J, Ni, M, Good, K, Cooke, G, Hanna, G, Ma, J, Moons, KGMC, de Groot, JAH, Altman, DG, Reitsma, JB, Collins, GS, Moons, KGM, Kamarudin, AN, Kolamunnage-Dona, R, Cox, T, Borsci, S, Pérez, T, Pardo, MC, Candela-Toha, A, Muriel, A, Zamora, J, Sanghera, S, Mohiuddin, S, Martin, R, Donovan, J, Coast, J, Seo, MK, Cairns, J, Mitchell, E, Smith, A, Wright, J, Hall, P, Messenger, M, Calder, N, Wickramasekera, N, Vinall-Collier, K, Lewington, A, Damen, J, Cairns, D, Hutchinson, M, Sturgeon, C, Mitchel, L, Kift, R, Christakoudi, S, Rungall, M, Mobillo, P, Montero, R, Tsui, T-L, Kon, SP, Tucker, B, Sacks, S, Farmer, C, Strom, T, Chowdhury, P, Rebollo-Mesa, I, Hernandez-Fuentes, M, Damen, JAAG, Debray, TPA, Heus, P, Hooft, L, Scholten, RJPM, Schuit, E, Tzoulaki, I, Lassale, CM, Siontis, GCM, Chiocchia, V, Roberts, C, Schlüssel, MM, Gerry, S, Black, JA, van der Schouw, YT, Peelen, LM, Spence, G, McCartney, D, van den Bruel, A, Lasserson, D, Hayward, G, Vach, W, de Jong, A, Burggraaff, C, Hoekstra, O, Zijlstra, J, de Vet, H, Graziadio, S, Allen, J, Johnston, L, O'Leary, R, Power, M, Johnson, L, Waters, R, Simpson, J, Fanshawe, TR, Phillips, P, Plumb, A, Helbren, E, Halligan, S, Gale, A, Sekula, P, Sauerbrei, W, Forman, JR, Dutton, SJ, Takwoingi, Y, Hensor, EM, Nichols, TE, Kempf, E, Porcher, R, de Beyer, J, Hopewell, S, Dennis, J, Shields, B, Jones, A, Henley, W, Pearson, E, Hattersley, A, MASTERMIND consortium, Scheibler, F, Rummer, A, Sturtz, S, Großelfinger, R, Banister, K, Ramsay, C, Azuara-Blanco, A, Burr, J, Kumarasamy, M, Bourne, R, Uchegbu, I, Murphy, J, Carter, A, Marti, J, Eatock, J, Robotham, J, Dudareva, M, Gilchrist, M, Holmes, A, Monaghan, P, Lord, S, StJohn, A, Sandberg, S, Cobbaert, C, Lennartz, L, Verhagen-Kamerbeek, W, Ebert, C, Horvath, A, Test Evaluation Working Group of the European Federation of Clinical Chemistry and Laboratory Medicine, Jenniskens, K, Peters, J, Grigore, B, Ukoumunne, O, Levis, B, Benedetti, A, Levis, AW, Ioannidis, JPA, Shrier, I, Cuijpers, P, Gilbody, S, Kloda, LA, McMillan, D, Patten, SB, Steele, RJ, Ziegelstein, RC, Bombardier, CH, Osório, FDL, Fann, JR, Gjerdingen, D, Lamers, F, Lotrakul, M, Loureiro, SR, Löwe, B, Shaaban, J, Stafford, L, van Weert, HCPM, Whooley, MA, Williams, LS, Wittkampf, KA, Yeung, AS, Thombs, BD, Cooper, C, Nieto, T, Smith, C, Tucker, O, Dretzke, J, Beggs, A, Rai, N, Bayliss, S, Stevens, S, Mallet, S, Sundar, S, Hall, E, Porta, N, Estelles, DL, de Bono, J, and CTC-STOP protocol development group
- Abstract
[This corrects the article DOI: 10.1186/s41512-016-0001-y.].
- Published
- 2017
27. Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations
- Author
-
Shawn Flanagan, Helen Walker, Voon Ong, and Taylor Sandison
- Subjects
rezafungin ,echinocandins ,drug-drug interactions ,pharmacokinetic profile ,cytochrome P450 ,drug transporters ,Microbiology ,QR1-502 - Abstract
ABSTRACT Rezafungin is a novel once-weekly echinocandin for intravenous injection currently in development for the treatment of Candida infections and the prevention of Candida, Aspergillus, and Pneumocystis infections in allogeneic blood and marrow transplant recipients. While in vitro data indicated that rezafungin exposure was unlikely to be affected by commonly prescribed medicines, interactions resulting in the altered systemic exposure of some drugs coadministered with rezafungin could not be excluded. Two phase 1 open label crossover studies, conducted in healthy subjects, examined drug interactions between rezafungin and multiple drug probe cytochrome P450 (CYP) substrates and/or transporter proteins, immunosuppressants, and cancer therapies. Statistical analysis compared the outcomes for drugs coadministered with rezafungin to those for the drugs administered alone. The geometric mean ratio was reported, and a default 90% confidence interval (CI) no-effect equivalence range of 80 to 125% was used for the maximal plasma concentration (Cmax), the area under the curve from time zero to the final sampling time point (AUC0–t), and the AUC from time zero to infinity (AUC0–∞). Most probes and concomitant drugs were within the equivalence range. For tacrolimus, ibrutinib, mycophenolic acid, and venetoclax, the AUC or Cmax was reduced (10 to 19%), with lower bounds of the 90% CI values falling outside the no-effect range. The rosuvastatin AUC and Cmax and the repaglinide AUC0–∞ were increased (12 to 16%), with the 90% CI being marginally above the upper bound. Overall, the in vitro and in vivo data demonstrated a low drug interaction potential with rezafungin via CYP substrate/transporter pathways and commonly prescribed comedications, suggesting that coadministration was unlikely to result in clinically significant effects. Treatment-emergent adverse events were typically mild, and rezafungin was generally well tolerated. IMPORTANCE Antifungal agents used to treat life-threatening infections are often associated with severe drug-drug interactions (DDIs) that may limit their usefulness. Rezafungin, a newly approved once-weekly echinocandin, has been shown to be free of DDIs based on extensive nonclinical and clinical testing described in this study.
- Published
- 2023
- Full Text
- View/download PDF
28. qMRI-BIDS: An extension to the brain imaging data structure for quantitative magnetic resonance imaging data
- Author
-
Agah Karakuzu, Stefan Appelhoff, Tibor Auer, Mathieu Boudreau, Franklin Feingold, Ali R. Khan, Alberto Lazari, Chris Markiewicz, Martijn Mulder, Christophe Phillips, Taylor Salo, Nikola Stikov, Kirstie Whitaker, and Gilles de Hollander
- Subjects
Science - Abstract
Abstract The Brain Imaging Data Structure (BIDS) established community consensus on the organization of data and metadata for several neuroimaging modalities. Traditionally, BIDS had a strong focus on functional magnetic resonance imaging (MRI) datasets and lacked guidance on how to store multimodal structural MRI datasets. Here, we present and describe the BIDS Extension Proposal 001 (BEP001), which adds a range of quantitative MRI (qMRI) applications to the BIDS. In general, the aim of qMRI is to characterize brain microstructure by quantifying the physical MR parameters of the tissue via computational, biophysical models. By proposing this new standard, we envision standardization of qMRI through multicenter dissemination of interoperable datasets. This way, BIDS can act as a catalyst of convergence between qMRI methods development and application-driven neuroimaging studies that can help develop quantitative biomarkers for neural tissue characterization. In conclusion, this BIDS extension offers a common ground for developers to exchange novel imaging data and tools, reducing the entrance barrier for qMRI in the field of neuroimaging.
- Published
- 2022
- Full Text
- View/download PDF
29. Comparison of a dichotomous versus trichotomous checklist for neonatal intubation
- Author
-
Lindsay Johnston, Taylor Sawyer, Akira Nishisaki, Travis Whitfill, Anne Ades, Heather French, Kristen Glass, Rita Dadiz, Christie Bruno, Orly Levit, and Marc Auerbach
- Subjects
Neonatal intubation ,Dichotomous checklist ,Trichotomous checklist ,Global skills assessment ,Entrustable professional activities assessment ,Special aspects of education ,LC8-6691 ,Medicine - Abstract
Abstract Background To compare validity evidence for dichotomous and trichotomous versions of a neonatal intubation (NI) procedural skills checklist. Methods NI skills checklists were developed utilizing an existing framework. Experts were trained on scoring using dichotomous and trichotomous checklists, and rated recordings of 23 providers performing simulated NI. Videolaryngoscope recordings of glottic exposure were evaluated using Cormack-Lehane (CL) and Percent of Glottic Opening scales. Internal consistency and reliability of both checklists were analyzed, and correlations between checklist scores, airway visualization, entrustable professional activities (EPA), and global skills assessment (GSA) were calculated. Results During rater training, raters gave significantly higher scores on better provider performance in standardized videos (both p
- Published
- 2022
- Full Text
- View/download PDF
30. A phase I randomized, double‐blind, single subcutaneous dose escalation study to determine the safety, tolerability, and pharmacokinetics of rezafungin in healthy adult subjects
- Author
-
Kenan Gu, Dennis Ruff, Cassandra Key, Marissa Thompson, Shoshanna Jiang, Taylor Sandison, and Shawn Flanagan
- Subjects
Therapeutics. Pharmacology ,RM1-950 ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Rezafungin is a novel echinocandin being developed for the treatment and prevention of invasive fungal infections. The objectives of this randomized, double‐blind study in healthy adults were to determine the safety, tolerability, and pharmacokinetics of rezafungin after subcutaneous (s.c.) administration. The study design consisted of six sequential cohorts of eight subjects, except for the first cohort with four subjects. The subjects were randomized in a 3:1 ratio of rezafungin to placebo and were to receive a single dose of 1, 10, 30, 60, 100, or 200 mg. The most common adverse events (AEs) were increased alanine aminotransferase and sinus bradycardia (unsolicited) and erythema at the injection site (solicited). Unsolicited AEs were generally mild to moderate and not rezafungin‐related. Although the study was terminated after the 10 mg dose cohort due to concerns of potential increased severity of injection site reactions, no predetermined dose escalation halting criteria were met. Following the 10 mg single s.c. dose of rezafungin (n = 6), the geometric mean (GM) maximum concentration (Cmax) was 105.0 ng/ml and the median time to Cmax was 144 h. The GM area under the concentration‐time curve was 32,770 ng*h/ml. The median estimated terminal half‐life was 193 h. The GM apparent oral clearance was 0.255 L/h and the GM apparent volume of distribution was 68.5 L. This study demonstrates that a single s.c. dose of rezafungin in healthy adult subjects: (1) did not result in serious AEs, death, or withdrawal from the study due to an AE; and (2) produced a pharmacokinetic profile with long exposure period postadministration. In an effort to reduce the occurrence of injection site reactions, a re‐evaluation of the rezafungin s.c. formulation could be considered in the future.
- Published
- 2022
- Full Text
- View/download PDF
31. Telecoaching Improves Positive Pressure Ventilation Performance During Simulated Neonatal Resuscitations
- Author
-
Mark Castera, Megan M. Gray, Carri Gest, Patrick Motz, Taylor Sawyer, and Rachel Umoren
- Subjects
telemedicine ,resuscitation ,simulation ,neonatal ,ventilation ,education ,Computer applications to medicine. Medical informatics ,R858-859.7 - Abstract
Introduction: Positive pressure ventilation (PPV) is a critical skill for neonatal resuscitation. We hypothesized that telecoaching would improve PPV performance in neonatal providers during simulated neonatal resuscitations. Setting: Level IV neonatal intensive care unit (NICU). Methods: This prospective crossover study included 14 experienced NICU nurses and respiratory therapists who performed PPV on a mannequin that recorded parameters of ventilation efficiency. Participants were randomized to practice independently (control) or with live feedback from a remote facilitator through audiovisual connection (intervention) and then switched to the opposite group. Participants' mask leak percentage, ventilation rates, and pressure delivery were analyzed. Results: The primary outcome of mask leak percentage was significantly increased in the telecoaching group (19% [interquartile range {IQR} 14?59.25] vs. 100% [IQR 88?100] leak, p?=?0.0001). The secondary outcome of peak inspiratory pressure (PIP) delivery was also increased (median 27.6 [IQR 23.5?34.7] vs. 23.3 [IQR 19.1?32.8] cmH2O, p?0.001). Differences in ventilation rates were not statistically significant (55 vs. 58 breaths/min, p?=?0.51). Conclusion: Participants demonstrated better PPV performance during telecoaching with less mask leak. The intervention group also had higher measured peak inspiratory pressures. Telecoaching may be a feasible method to provide real-time feedback to health care providers during simulated neonatal resuscitations. Hypothesis: Neonatal providers who receive telecoaching during simulated resuscitations will perform PPV more effectively than those who do not receive telecoaching.
- Published
- 2022
- Full Text
- View/download PDF
32. PET-BIDS, an extension to the brain imaging data structure for positron emission tomography
- Author
-
Martin Norgaard, Granville J. Matheson, Hanne D. Hansen, Adam Thomas, Graham Searle, Gaia Rizzo, Mattia Veronese, Alessio Giacomel, Maqsood Yaqub, Matteo Tonietto, Thomas Funck, Ashley Gillman, Hugo Boniface, Alexandre Routier, Jelle R. Dalenberg, Tobey Betthauser, Franklin Feingold, Christopher J. Markiewicz, Krzysztof J. Gorgolewski, Ross W. Blair, Stefan Appelhoff, Remi Gau, Taylor Salo, Guiomar Niso, Cyril Pernet, Christophe Phillips, Robert Oostenveld, Jean-Dominique Gallezot, Richard E. Carson, Gitte M. Knudsen, Robert B. Innis, and Melanie Ganz
- Subjects
Science - Abstract
The Brain Imaging Data Structure (BIDS) is a standard for organizing and describing neuroimaging datasets, serving not only to facilitate the process of data sharing and aggregation, but also to simplify the application and development of new methods and software for working with neuroimaging data. Here, we present an extension of BIDS to include positron emission tomography (PET) data, also known as PET-BIDS, and share several open-access datasets curated following PET-BIDS along with tools for conversion, validation and analysis of PET-BIDS datasets.
- Published
- 2022
- Full Text
- View/download PDF
33. Exploring the Effect of Age on the Reproductive and Stress Physiology of Octopus bimaculoides Using Dermal Hormones
- Author
-
Stephanie Chancellor, Bret Grasse, Taylor Sakmar, David Scheel, Joel S. Brown, and Rachel M. Santymire
- Subjects
California two-spot octopus ,cortisol ,estradiol ,progesterone ,senescence ,testosterone ,Veterinary medicine ,SF600-1100 ,Zoology ,QL1-991 - Abstract
Our goal was to validate the use of dermal swabs to evaluate both reproductive and stress physiology in the California two-spot octopus, Octopus bimaculoides. Our objectives were to (1) use dermal swabs to evaluate glucocorticoids and reproductive hormones of O. bimaculoides; (2) determine the influence of life stage on hormone production (glucocorticoids in all individuals; testosterone, estrogen, and progesterone in females; and testosterone in males) of reproductive (n = 4) and senescent (n = 8) individuals to determine the effect of age on hormonal patterns; and (3) determine whether these hormones change significantly in response to an acute stressor. For the stress test, individuals were first swabbed for a baseline and then chased around the aquarium with a net for 5 min. Afterward, individuals were swabbed for 2 h at 15 min intervals to compare to the pre-stress test swab. Reproductive individuals responded to the stressor with a 2-fold increase in dermal cortisol concentrations at 15 and 90 min. Six of the eight senescent individuals did not produce a 2-fold increase in dermal cortisol concentrations. Reproductive individuals had significantly higher sex hormone concentrations compared to senescent individuals (progesterone and estradiol measured in females, and testosterone for both sexes). After the stressor, only reproductive males produced a 2-fold increase in dermal testosterone concentrations, while sex hormones in females showed no change. The stress hormone cortisol was significantly higher in senescent than in reproductive individuals, independent of sex. Dermal corticosterone concentrations were highest in senescent females followed by senescent males, and lowest in reproductive individuals regardless of sex. Dermal swabs provide an effective and noninvasive means for evaluating octopus hormones. Application of these indicators may be imperative as cephalopods are more commonly cultured in captivity for experimentation, display, and consumption.
- Published
- 2023
- Full Text
- View/download PDF
34. Clinical indications for computed tomographic colonography: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline
- Author
-
Spada, C, Stoker, J, Alarcon, O, Barbaro, F, Bellini, D, Bretthauer, M, de Haan, MC, Dumonceau, JM, Ferlitsch, M, Halligan, S, Helbren, E, Hellstrom, M, Kuipers, Ernst, Lefere, P, Mang, T, Neri, E, Petruzziello, L, Plumb, A, Regge, D, Taylor, SA, Hassan, C, Laghi, A, Spada, C, Stoker, J, Alarcon, O, Barbaro, F, Bellini, D, Bretthauer, M, de Haan, MC, Dumonceau, JM, Ferlitsch, M, Halligan, S, Helbren, E, Hellstrom, M, Kuipers, Ernst, Lefere, P, Mang, T, Neri, E, Petruzziello, L, Plumb, A, Regge, D, Taylor, SA, Hassan, C, and Laghi, A
- Published
- 2015
35. Microscopy-BIDS: An Extension to the Brain Imaging Data Structure for Microscopy Data
- Author
-
Marie-Hélène Bourget, Lee Kamentsky, Satrajit S. Ghosh, Giacomo Mazzamuto, Alberto Lazari, Christopher J. Markiewicz, Robert Oostenveld, Guiomar Niso, Yaroslav O. Halchenko, Ilona Lipp, Sylvain Takerkart, Paule-Joanne Toussaint, Ali R. Khan, Gustav Nilsonne, Filippo Maria Castelli, The BIDS Maintainers, Julien Cohen-Adad, Stefan Appelhoff, Ross Blair, Eric Earl, Franklin Feingold, Anthony Galassi, Rémi Gau, and Taylor Salo
- Subjects
microscopy ,open science ,data structure ,data sharing ,specification ,standardization ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
The Brain Imaging Data Structure (BIDS) is a specification for organizing, sharing, and archiving neuroimaging data and metadata in a reusable way. First developed for magnetic resonance imaging (MRI) datasets, the community-led specification evolved rapidly to include other modalities such as magnetoencephalography, positron emission tomography, and quantitative MRI (qMRI). In this work, we present an extension to BIDS for microscopy imaging data, along with example datasets. Microscopy-BIDS supports common imaging methods, including 2D/3D, ex/in vivo, micro-CT, and optical and electron microscopy. Microscopy-BIDS also includes comprehensible metadata definitions for hardware, image acquisition, and sample properties. This extension will facilitate future harmonization efforts in the context of multi-modal, multi-scale imaging such as the characterization of tissue microstructure with qMRI.
- Published
- 2022
- Full Text
- View/download PDF
36. Copper-Triazole Interaction and Coolant Inhibitor Depletion
- Author
-
Bartley, LS, primary, Fritz, PO, additional, Pellet, RJ, additional, Taylor, SA, additional, and Van de Ven, P, additional
- Full Text
- View/download PDF
37. PWE-033 Comparison Of Patient Experience Of Colonoscopy And Ct Colonography In The English Bowel Cancer Screening Programme
- Author
-
Plumb, AA, primary, Ghanouni, A, additional, Rees, CJ, additional, Hewitson, P, additional, Miller, H, additional, Bevan, R, additional, Taylor, SA, additional, Halligan, S, additional, and von Wagner, C, additional
- Published
- 2014
- Full Text
- View/download PDF
38. Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting.
- Author
-
Beets Tan, Rg, Lambregts, Dm, Maas, M, Bipat, S, Barbaro, Brunella, Caseiro Alves, F, Curvo Semedo, L, Fenlon, Hm, Gollub, Mj, Gourtsoyianni, S, Halligan, S, Hoeffel, C, Kim, Sh, Laghi, A, Maier, A, Rafaelsen, Sr, Stoker, J, Taylor, Sa, Torkzad, Mr, Blomqvist, L., Barbaro, Brunella (ORCID:0000-0002-9638-543X), Beets Tan, Rg, Lambregts, Dm, Maas, M, Bipat, S, Barbaro, Brunella, Caseiro Alves, F, Curvo Semedo, L, Fenlon, Hm, Gollub, Mj, Gourtsoyianni, S, Halligan, S, Hoeffel, C, Kim, Sh, Laghi, A, Maier, A, Rafaelsen, Sr, Stoker, J, Taylor, Sa, Torkzad, Mr, Blomqvist, L., and Barbaro, Brunella (ORCID:0000-0002-9638-543X)
- Abstract
OBJECTIVES: To develop guidelines describing a standardised approach regarding the acquisition, interpretation and reporting of magnetic resonance imaging (MRI) for clinical staging and restaging of rectal cancer. METHODS: A consensus meeting of 14 abdominal imaging experts from the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) was conducted following the RAND-UCLA Appropriateness Method. Two independent (non-voting) chairs facilitated the meeting. Two hundred and thirty-six items were scored by participants for appropriateness and classified subsequently as appropriate or inappropriate (defined by ≥ 80 % consensus) or uncertain (defined by < 80 % consensus). Items not reaching 80 % consensus were noted. RESULTS: Consensus was reached for 88 % of items: recommendations regarding hardware, patient preparation, imaging sequences, angulation, criteria for MRI assessment and MRI reporting were constructed from these. CONCLUSIONS: These expert consensus recommendations can be used as clinical guidelines for primary staging and restaging of rectal cancer using MRI.
- Published
- 2013
39. The Lesser Pacific Striped Octopus, Octopus chierchiae: An Emerging Laboratory Model
- Author
-
Anik G. Grearson, Alison Dugan, Taylor Sakmar, Dominic M. Sivitilli, David H. Gire, Roy L. Caldwell, Cristopher M. Niell, Gül Dölen, Z. Yan Wang, and Bret Grasse
- Subjects
iteroparity ,cephalopod ,model organism ,aquaculture ,reproduction – mollusk ,developmental biology ,Science ,General. Including nature conservation, geographical distribution ,QH1-199.5 - Abstract
Cephalopods have the potential to become useful experimental models in various fields of science, particularly in neuroscience, physiology, and behavior. Their complex nervous systems, intricate color- and texture-changing body patterns, and problem-solving abilities have attracted the attention of the biological research community, while the high growth rates and short life cycles of some species render them suitable for laboratory culture. Octopus chierchiae is a small octopus native to the central Pacific coast of North America whose predictable reproduction, short time to maturity, small adult size, and ability to lay multiple egg clutches (iteroparity) make this species ideally suited to laboratory culture. Here we describe novel methods for multigenerational culture of O. chierchiae, with emphasis on enclosure designs, feeding regimes, and breeding management. O. chierchiae bred in the laboratory grow from a 3.5 mm mantle length at hatching to an adult mantle length of approximately 20–30 mm in 250–300 days, with 15 and 14% survivorship to over 400 days of age in first and second generations, respectively. O. chierchiae sexually matures at around 6 months of age and, unlike most octopus species, can lay multiple clutches of large, direct-developing eggs every ∼30–90 days. Based on these results, we propose that O. chierchiae possesses both the practical and biological features needed for a model octopus that can be cultured repeatedly to address a wide range of biological questions.
- Published
- 2021
- Full Text
- View/download PDF
40. Living with AMD treatment - a qualitative study.
- Author
-
Knox, PC, Thetford, Clare, Hodge, S, Harding, SP, Taylor, SA, Knox, PC, Thetford, Clare, Hodge, S, Harding, SP, and Taylor, SA
- Abstract
Purpose: Anti-VegF therapy for the treatment of neovascular AMD has clear clinical and quality of life benefits, as shown in numerous well conducted studies. It is now being implemented in many healthcare systems. However, treatment often involves multiple assessments and intravitreal drug injections, usually over an extended period of time. How do patients view this process, particularly at the outset, and how does their actual experience affect their views? Methods: Fifteen patients (mean age 76y; 6 males) were recruited and interviewed using the Biographical Narrative Interview Method (BNIM) before or just after treatment was commenced. At the end of the BNIM interview, a VFQ25 was also completed. Nine patients were interviewed several months later after they had received at least the loading dose of three injections. A semi-structured interview technique was used and the MacTSQ (a specific treatment satisfaction questionnaire, in which patients score their most recent treatment episode) administered. Interview data was subjected to thematic analysis, and VFQ25 and MacTSQ data scored and collated in accordance with published procedures. Results: The intersubject mean (±SD) VFQ25 General Health and General Vision scores were 57±29 and 61±26 respectively; Near Activities scored 65±32. In BNIM interviews almost all patients said that they had known relatively little about what treatment would entail other than that it required injections into their eye. They reported considerable apprehension pre-treatment. However, post-treatment interview data demonstrated that this apprehension was defused by actual treatment experience. None experienced serious adverse events, and few reported experiencing serious discomfort. Where this did occur, it did not discourage patients from continuing with treatment. These reports were complemented by the Mac TSQ data. The mean overall score was 65±5/72 (a higher score indicates greater satisfaction). Item 6 specifically asks "How appre
- Published
- 2012
41. Use of molecular genetics for understanding seabird evolution, ecology and conservation
- Author
-
Taylor, SA, primary and Friesen, VL, additional
- Published
- 2012
- Full Text
- View/download PDF
42. At-sea movement patterns and diving behavior of Peruvian boobies Sula variegata in northern Peru
- Author
-
Zavalaga, CB, primary, Halls, JN, additional, Mori, GP, additional, Taylor, SA, additional, and Dell’omo, G, additional
- Published
- 2010
- Full Text
- View/download PDF
43. Correct diagnosis of childhood pneumonia in public facilities in Tanzania: a randomised comparison of diagnostic methods
- Author
-
Alice Redfern, Ntuli A Kapologwe, Taylor Salisbury, Erin K Fletcher, Jean Arkedis, Felix Bundala, Alison Connor, Julius Massaga, Naibu Mkongwa, Balowa Musa, and Cammie Lee
- Subjects
Medicine - Abstract
Objective This study compares two methods for clinical diagnosis of childhood pneumonia that aim to estimate rates of underdiagnosis and overdiagnosis of childhood pneumonia by examining the sensitivity of Integrated Management of Childhood Diseases implementation in routine care against lung ultrasound (LUS) diagnosis.Setting We conducted observations in 83 public health facilities (dispensaries, health centres and district hospitals) in Pwani, Dodoma and Tabora, Tanzania between October and December 2017.Methods We used a novel method to estimate rates of underdiagnosis and overdiagnosis of childhood pneumonia by comparing directly observed public provider diagnoses to the results of diagnoses made by trained clinicians using Mindray DP-10 ultrasound machines. We perform multivariate analysis to identify confounding effects and robustness checks to bound the result. We also explore a number of observable characteristics correlated with higher rates of agreement between provider diagnoses and ultrasound diagnoses.Results We observed 93 providers conducting exams on patients aged 2 months–5 years who presented respiratory symptoms or were given a respiratory diagnosis by the provider. Of these 957 patients, 110 were excluded from analysis resulting in a final sample of 847.17.6% of cases identified as pneumonia via LUS examinations in our sample were diagnosed as pneumonia by providers, suggesting that a significant number of pneumonia cases for which care is sought in the public sector go undiagnosed. Provider knowledge of breath counting and years of experience are positively correlated with higher agreement. While clinical examination rates are not statistically correlated with agreement, it is notable that providers conducted a clinical examination on only about one-third of patients in the sample.Conclusion Our results suggest that provider training and knowledge of clinical examination protocols for pneumonia diagnosis are predictive of correct diagnosis of pneumonia and should be further explored in future research as a tool for improving quality of care.
- Published
- 2021
- Full Text
- View/download PDF
44. Dynamics of papillomavirus in vivo disease formation & susceptibility to high-level disinfection—Implications for transmission in clinical settings
- Author
-
Nagayasu Egawa, Aslam Shiraz, Robin Crawford, Taylor Saunders-Wood, Jeremy Yarwood, Marc Rogers, Ankur Sharma, Gary Eichenbaum, and John Doorbar
- Subjects
HPV, nosocomial transmission ,Virus disinfection ,Cervical cancer ,Methodology for virus infection assay ,High-level disinfectant ,Medicine ,Medicine (General) ,R5-920 - Abstract
Background: High-level disinfection protects tens-of-millions of patients from the transmission of viruses on reusable medical devices. The efficacy of high-level disinfectants for preventing human papillomavirus (HPV) transmission has been called into question by recent publications, which if true, would have significant public health implications. Methods: Evaluation of the clinical relevance of these published findings required the development of novel methods to quantify and compare: (i) Infectious titres of lab-produced, clinically-sourced, and animal-derived papillomaviruses, (ii) The papillomavirus dose responses in the newly developed in vitro and in vivo models, and the kinetics of in vivo disease formation, and (iii) The efficacy of high-level disinfectants in inactivating papillomaviruses in these systems. Findings: Clinical virus titres obtained from cervical lesions were comparable to those obtained from tissue (raft-culture) and in vivo models. A mouse tail infection model showed a clear dose-response for disease formation, that papillomaviruses remain stable and infective on fomite surfaces for at least 8 weeks without squames and up to a year with squames, and that there is a 10-fold drop in virus titre with transfer from a fomite surface to a new infection site. Disinfectants such as ortho-phthalaldehyde and hydrogen peroxide, but not ethanol, were highly effective at inactivating multiple HPV types in vitro and in vivo. Interpretation: Together with comparable results presented in a companion manuscript from an independent laboratory, this work demonstrates that high-level disinfectants inactivate HPV and highlights the need for standardized and well-controlled methods to assess HPV transmission and disinfection. Funding: Advanced Sterilization Products, UK-MRC (MR/S024409/1 and MC-PC-13050) and Addenbrookes Charitable Trust
- Published
- 2021
- Full Text
- View/download PDF
45. Adverse effects of chronic low level lead exposure on kidney function - a risk group study in children
- Author
-
UCL - MD/ESP - Ecole de santé publique, Fels, LM., Wunsch, M, Baranowski, J, Norska-Borowka, I, Price, RG., Taylor, SA., Patel, S, De Broe, M, Elseviers, MM, Lauwerys, Robert, Roels, Harry, Bernard, Alfred, Mutti, A., Gelpi, E, Rosello, J, Stolte, H., UCL - MD/ESP - Ecole de santé publique, Fels, LM., Wunsch, M, Baranowski, J, Norska-Borowka, I, Price, RG., Taylor, SA., Patel, S, De Broe, M, Elseviers, MM, Lauwerys, Robert, Roels, Harry, Bernard, Alfred, Mutti, A., Gelpi, E, Rosello, J, and Stolte, H.
- Abstract
Background. Children have been considered a risk group for lead (Pb) toxicity, mainly because of neurophysiological or neuro-cognitive deficits following rb exposure. Blood Pb levels (b-Pb) of 100 mu g/l currently have been defined as the lowest adverse effect level. The aim of this study was to compare, with the help of urinary markers, the kidney function of children with b-Pb just above this threshold with that of unexposed children, to assess from a nephrological point of view whether the current threshold is justified and whether children really are a particularly vulnerable risk group in terms of Pb-induced kidney damage. Methods. In a cross-sectional study, 112 children, either from unexposed areas (controls, n = 50) or Pb-contaminated areas (n = 62), the latter partly with a known history of elevated b-Pb, were examined. Twenty nine urinary or serum markers mostly related to the function or integrity of specific nephron segments were determined (e.g. filtered plasma proteins, tubular enzymes, tubular antigens, eicosanoids). Results. b-Pb were 39 +/- 13 mu g/l in controls and 133 +/- 62 mu g/l in exposed children. The main findings were increased excretion rates of prostaglandins and thromboxane B-2, epidermal growth factor, beta(2)-microglobulin and Clara cell protein in the exposed children. A relationship between b-Pb and the prevalence of values above the upper reference limits was observed. Conclusions, With the help of urinary markers, nephron segment-specific effects of chronic low-level Pb exposure could be detected in children. The pattern of effects on glomerular, proximal and distal tubular and interstitial markers was similar to that previously observed in adults. The changes, however, occur at lower b-Pb levels than in adults. The current threshold appears to be justified also from a nephrological point of view, and children can indeed be considered a special risk group.
- Published
- 1998
46. Markers of Early Renal Changes Induced By Industrial Pollutants .3. Application To Workers Exposed To Cadmium
- Author
-
UCL - MD/ESP - Ecole de santé publique, Roels, Harry, Bernard, AM., Cardenas Flores, Antonio, Buchet, Jean-Pierre, Lauwerys, Robert, Hotter, G., Ramis, I., Mutti, A., Franchini, I., Bundschuh, I., Stolte, H., Debroe, ME., Nuyts, GD., Taylor, SA., Price, RG., UCL - MD/ESP - Ecole de santé publique, Roels, Harry, Bernard, AM., Cardenas Flores, Antonio, Buchet, Jean-Pierre, Lauwerys, Robert, Hotter, G., Ramis, I., Mutti, A., Franchini, I., Bundschuh, I., Stolte, H., Debroe, ME., Nuyts, GD., Taylor, SA., and Price, RG.
- Abstract
Cadmium (Cd) was the third heavy metal investigated in the European collaborative research project on the development and validation of new markers of nephrotoxicity. Fifty workers exposed to Cd and 50 control workers were examined. After application of selection criteria 37 workers (mean age 43) exposed to Cd for an average of 11-3 years; and 43 age matched referents were retained for final analysis. The average concentrations of Cd in blood (Cd-B) and urine (Cd-U) of exposed workers were 5.5 mug Cd/l and 5.4 mug Cd/g creatinine respectively. By contrast with lead and mercury, Cd had a broad spectrum of effects on the kidney, producing significant alterations in amounts of almost all potential indicators of nephrotoxicity that were measured in urine-namely, low and high molecular weight proteins, kidney derived antigens or enzymes, prostanoids, and various other biochemical indices such as glycosaminoglycans and sialic acid. An increase in beta2-microglobulin and a decrease of sialic acid concentration were found in serum. Dose-effect/response relations could be established between most of these markers and Cd-U or Cd-B. The thresholds of Cd-U associated with a significantly higher probability of change in these indicators were estimated by logistic regression analysis. Three main groups of thresholds could be identified: one around 2 mug Cd/g creatinine mainly associated with biochemical alterations, a second around 4 mug Cd/g creatinine for high molecular weight proteins and some tubular antigens or enzymes, and a third one around 10 mug Cd/g creatinine for low molecular weight proteins and other indicators. The recent recommendation by the American Conference of Governmental Industrial Hygienists (ACGIH) of 5 mug Cd/g creatinine in urine as the biological exposure limit for occupational exposure to Cd appears thus justified, although for most of the effects occurring around this threshold the link with the subsequent development of overt Cd nephropathy is not es
- Published
- 1993
47. Markers of Early Renal Changes Induced By Industrial Pollutants .1. Application To Workers Exposed To Mercury-vapor
- Author
-
UCL - MD/ESP - Ecole de santé publique, Cardenas Flores, Antonio, Roels, Harry, Bernard, AM., Barbon, R., Buchet, Jean-Pierre, Lauwerys, Robert, Rosello, J., Hotter, G., Mutti, A., Franchini, I., Fels, LM., Stolte, H., Debroe, ME., Nuyts, GD., Taylor, SA., Price, RG., UCL - MD/ESP - Ecole de santé publique, Cardenas Flores, Antonio, Roels, Harry, Bernard, AM., Barbon, R., Buchet, Jean-Pierre, Lauwerys, Robert, Rosello, J., Hotter, G., Mutti, A., Franchini, I., Fels, LM., Stolte, H., Debroe, ME., Nuyts, GD., Taylor, SA., and Price, RG.
- Abstract
Several markers of renal changes have been measured in a cohort of 50 workers exposed to elemental mercury (Hg) and in 50 control workers. After application of selection criteria 44 exposed and 49 control workers were retained for the final statistical analysis. Exposed workers excreted on average 22 mug Hg/g creatinine and their mean duration of exposure was 11 years. Three types of renal markers were studied-namely, functional markers (creatinine and beta2-microglobulin in serum, urinary proteins of low or high molecular weight); cytotoxicity markers (tubular antigens and enzymes in urine), and biochemical markers (eicosanoids, thromboxane, fibronectin, kallikrein, sialic acid, glycosaminoglycans in urine, red blood cell membrane negative charges). Several blood-borne indicators of polyclonal activation were also measured to test the hypothesis that an immune mechanism might be involved in the renal toxicity of elemental Hg. The main renal changes associated with exposure to Hg were indicative of tubular cytotoxicity (increased leakage of tubular antigens and enzymes in urine) and biochemical alterations (decreased urinary excretion of some eicosanoids and glycosaminoglycans and lowering of urinary pH). The concentrations of anti-DNA antibodies and total immunoglobulin E in serum were also positively associated with the concentration of Hg in urine and in blood respectively. The renal effects were mainly found in workers excreting more than 50 mug Hg/g creatinine, which corroborates our previous estimate of the biological threshold of Hg in urine. As these effects, however, were unrelated to the duration of exposure and not accompanied by functional changes (for example, microproteinuria), they may not necessarily represent clinically significant alterations of renal function.
- Published
- 1993
48. Markers of Early Renal Changes Induced By Industrial Pollutants .2. Application To Workers Exposed To Lead
- Author
-
UCL - MD/ESP - Ecole de santé publique, Cardenas Flores, Antonio, Roels, Harry, Bernard, AM., Barbon, R., Buchet, Jean-Pierre, Lauwerys, Robert, Rosello, J., Ramis, I., Mutti, A., Franchini, I., Fels, LM., Stolte, H., Debroe, ME., Nuyts, GD., Taylor, SA., Price, RG., UCL - MD/ESP - Ecole de santé publique, Cardenas Flores, Antonio, Roels, Harry, Bernard, AM., Barbon, R., Buchet, Jean-Pierre, Lauwerys, Robert, Rosello, J., Ramis, I., Mutti, A., Franchini, I., Fels, LM., Stolte, H., Debroe, ME., Nuyts, GD., Taylor, SA., and Price, RG.
- Abstract
The present study has been carried out in the framework of a collaborative research project on the development of new markers of nephrotoxicity. A battery of more than 20 potential indicators of renal changes has been applied to 50 workers exposed to lead (Pb) and SO control subjects. After application of selection criteria 41 exposed and 41 control workers were eventually retained for the final statistical analysis. The average blood Pb concentration of exposed workers was 480 mug/l and their mean duration of exposure was 14 years. The battery of tests included parameters capable of detecting functional deficits (for example, urinary proteins of low or high molecular weight), biochemical alterations (for example, urinary eicosanoids, glycosaminoglycans, sialic acid) or cell damage (for example, urinary tubular antigens or enzymes) at different sites of the nephron or the kidney. The most outstanding effect found in workers exposed to Pb was an interference with the renal synthesis of eicosanoids, resulting in lower urinary excretion of 6-keto-PGF1alpha and an enhanced excretion of thromboxane (TXB2). The health significance of these biochemical alterations, detectable at low exposure to Pb is unknown. As they were not associated with any sign of renal dysfunction, they may represent reversible biochemical effects or only contribute to the degradation of the renal function from the onset of clinical Pb nephropathy. The urinary excretion of some tubular antigens was also positively associated with duration of exposure to Pb. Another effect of Pb that might deserve further study is a significant increase in urinary sialic acid concentration.
- Published
- 1993
49. Nephropathies and exposure to perchloroethylene in dry-cleaners
- Author
-
UCL - MD/ESP - Ecole de santé publique, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Centre de toxicologie clinique, Mutti, A., Alinovi, R., Bergamaschi, E., Biagini, C., Cavazzini, S., Franchini, I., Lauwerys, Robert, Bernard, Alfred, Roels, Harry, Gelpí, E., Rosello, J., Ramis, I., Price, RG., Taylor, SA., Debroe, M., Nuyts, GD., Stolte, H., Fels, LM., Herbort, C., UCL - MD/ESP - Ecole de santé publique, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Centre de toxicologie clinique, Mutti, A., Alinovi, R., Bergamaschi, E., Biagini, C., Cavazzini, S., Franchini, I., Lauwerys, Robert, Bernard, Alfred, Roels, Harry, Gelpí, E., Rosello, J., Ramis, I., Price, RG., Taylor, SA., Debroe, M., Nuyts, GD., Stolte, H., Fels, LM., and Herbort, C.
- Abstract
Even in specific risk groups, the relation between exposure to organic solvents and chronic renal diseases remains controversial. Thus, in a collaborative European study, we assessed the renal effects of occupational exposure to perchloroethylene (PCE) in dry-cleaners compared with matched controls who were simultaneously examined. Single high and low molecular weight proteins, kidney-derived antigens and enzymes, and prostanoids were measured in urine. Beta-2-microglobulin, creatinine, laminin fragments, and anti-glomerular basement membrane antibodies were also measured in serum. A canonical function based on 23 such variables correctly classified 93% of individuals as either PCE-exposed or controls; with 13 markers, group membership was identified in 87% of subjects. Increased high molecular weight protein in urine was frequently (17/50 vs 1/50, p < 0.0001) associated with tubular alterations. Changes were consistent with diffuse abnormalities along the nephron in workers exposed to low levels of PCE (median 15 parts per million). Generalised membrane disturbances might account for the increased release of laminin fragments, fibronectin, and glycosaminoglycans, for high molecular weight proteinuria, and for the increased shedding of epithelial membrane components from tubular cells with different location along the nephron (brush-border-antigens and Tamm-Horsfall glycoprotein). These findings of early renal changes indicate that solvent-exposed subjects, especially dry-cleaners, need to be monitored for the possible development of chronic renal diseases.
- Published
- 1992
50. Direct detection of a common inversion mutation in the genetic diagnosis of severe hemophilia A [see comments]
- Author
-
Windsor, S, primary, Taylor, SA, additional, and Lillicrap, D, additional
- Published
- 1994
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.